°Q½×°Ï>ªYÄ£¥ÍÂå
¥«³õ­º¨£·sÃÄ ±ÂÅv½Í¤¤
·|­û:hung1201 10149413 µoªí®É¶¡:2020/6/24 ¤U¤È 02:11:23
¥«³õ­º¨£·sÃÄ(¥þ²y¥«³õ¨C¦~¬ù350-400»õ¬ü¤¸) Àø®Ä¤ÀªR p=0.009

6634 ªYÄ£

ªÑ¥»: 3.832»õ

¥D­n·~°È:

¨xŦ¯e¯fªvÀø¤Î¯kµhªvÀø¬ÛÃöÃĪ«¬ã¨s¤Î¶}µo

¸³ºÊ«ùªÑ¤ñ¨Ò: 21.7%(¼W¥[¤¤)

¥~¸ê«ùªÑ¤ñ¨Ò: 0.22%(¼W¥[¤¤)

Ä~Äò©¹¤U¬Ý...!

=============================================================================

²£«~01¡GSNP-610 (ªvÀø¯×ªÕ¨x¯e¯f·sÃÄ)

¾AÀ³¯g: «D°sºë©Ê¯×ªÕ¨xª¢

²£«~Àu¶Õ:

1.¥Ø«e©|µL¼Ð·ÇªvÀøÃĪ«

2.¥«³õ­º¨£·sÃÄ(First-in-class)

3.¦P®É¥i¥Î©ó°sºë©Ê©M«D°sºë©Ê¯×ªÕ¨x

4.µL¦w¥þ©Ê°ÝÃD

¥«³õ: «D°sºë©Ê¯×ªÕ¨xª¢¥þ²y¥«³õ¨C¦~¬ù350-400»õ¬ü¤¸¡C

Ävª§¤O:

1.¦h­«§@¥Î¾÷Âà:ªvÀø¤Î¹w¨¾¯×ªÕ¨xª¢

2.ª½±µ§@¥Î©ó¨xŦ¡AªvÀø¯×ªÕ¨xª¢¡A­°§C¨x¯×

3.¥i´£¥X¨uÃĥӽСAÀ³¥Î©óªvÀø§³®W«æ©Ê¯×ªÕ¨x

¬ãµo¶¥¬q:

1.¤w³q¹LUSFDA¤ÎTFDA¼f¬d¶i¤JÁ{§É¤G´Á

2.Á{§ÉÀø®Ä¤Î·sªvÀø¾÷ÂàÅçÃÒ

Àø®Ä¤ÀªR¡G

1.²Ä¤@´ÁÁ{§É¸ÕÅç¡Gµ²ªGÅã¥Ü¤HÅé¨Ï¥Î¦w¥þ¡A©Ê½è¨}¦n

2.²Ä¤G´ÁÁ{§É¸ÕÅç¨ä¤¤¤ÀªR¡G17¦ìNASH ¯f¤H (p=0.009)

=============================================================================

²£«~02¡GSNP-630

¾AÀ³¯g:«D°sºë©Ê¯×ªÕ¨xª¢

²£«~Àu¶Õ:

1.¬°Àu¤Æ(Optimized)¤§·s¤Æ¾Ç¹êÅé(NCE)

2.¥«³õ­º¨£·sÃÄ(First-in-class)

3.¦P®É¥i¥Î©ó°sºë©Ê©M«D°sºë©Ê¯×ªÕ¨x

4.§@¬°²Ä¤@¥N²£«~¤W¥««áªº±µÄò¦û¦³¥«³õ¤§²£«~

¥«³õ: «D°sºë©Ê¯×ªÕ¨xª¢¥þ²y¥«³õ¨C¦~¬ù350-400»õ¬ü¤¸¡C

Ävª§¤O:

1.¦h­«§@¥Î¾÷Âà:ªvÀø¤Î¹w¨¾¯×ªÕ¨xª¢

2.ª½±µ§@¥Î©ó¨xŦ¡AªvÀø¯×ªÕ¨xª¢¡A­°§C¨x¯×

3.Àu¤ÆªºÀø®Ä±j«×¡B§@¥Î®É¶¡

4.µL¦w¥þ©Ê°ÝÃD

¬ãµo¶¥¬q:

1.Á{§É«e

2.¹w©w¥Ó½Ð¬ü°êFDAIND¡B§Ö³t³q¹D(fasttrack)¡C

3.¥Ó½Ð¬ü°ê¬ð¯}©ÊªvÀø(breakthrough therapy)ªº»{©w¡C

Àø®Ä¤ÀªR¡G

1. ¥Ø«e¦b°Êª«¤W¥H¤£¦P¾¯¶q¶i¦æ¸ÕÅç¡Aµ²ªGÅã¥Ü p<0.05

=============================================================================

²£«~03¡GSNP-810 (µL¨x¬r©Ê¤îµh·sÃÄ¡B¸Ñ¬r¾¯)

¾AÀ³¯g: µL¨x¬r©Ê¤AñQÓi×ô¤îµhÃÄ (¸Ñ¼öÂíµh¾¯)

²£«~Àu¶Õ:

1.¦w¥þ¤Æ¦Xª«·s²Õ¦X¡BµL¨x¬r©Ê

2.¸Ñ¨M­¢¤ÁÂåÀø»Ý¨D (Important urgent unmet medical needs)

3.¦³¾¯«¬±M§Q¡A¦w¥þ½d³ò¤j¡A¥i­×§ï©Î§R°£FDA¨x¬rĵ»y¥i¼W¥[¾¯¶q

¥«³õ: ¤AñQÓi×ô¶È¦b¬ü°ê¤@¦~´N¦³40»õ¬ü¤¸ªº¥«³õ

Ävª§¤O:

1.¥«³õ¤WµLÃþ¦üµL¨x¬r©Ê¤§Ävª§ÃĪ«

2.¥i§ð¦û¼s¤j¥«³õ¡]NSAID, COX-2 §í¨î¾¯¡BOpioidsÃþ¤îµhÃÄ¥«³õ¡^

3.¥i¬Ù°£¶D³^¶O¡B±Ð¨|°V½m¶O

¬ãµo¶¥¬q:

1.¤w§¹¦¨§C¾¯¶q¡B°ª¾¯¶qÁ{§É¸ÕÅç

2.¤w¥Ó½ÐUSFDA¼Ï&#32445;Á{§É¸ÕÅç¡B±N¥Ó½Ð¬ð¯}©Ê¼f¬d/§Ö³t³q¹D

3.µL¨x¬r©Ê¤AñQÓi×ô¸Ñ¬r¾¯¦¨¤À¡A¤w¥Ó½Ð¬dÅçµn°O¥Î¤§Á{§É¸ÕÅç

=============================================================================

²£«~04¡GSNP-830/ SNP-840

¾AÀ³¯g: µL¨x¬r©Ê¤AñQÓi×ô¤îµhÃĽƤè(ªvÀø¤¤¡B­««×¯kµh)

²£«~Àu¶Õ:

1.µL¨x¬r©Ê¤AñQÓi×ôªº½Æ¤è

2.¦³¾¯«¬±M§Q¡A¦w¥þ½d³ò¤j¡A¥i­×§ï©Î§R°£FDA¨x¬rĵ»y¡A¥i¼W¥[¾¯¶q

¥«³õ: ¤AñQÓi×ô³B¤èÃĦb¬ü°ê¤@¦~´N¦³27»õ¬ü¤¸ªº¥«³õ

Ävª§¤O:

1.¥«³õ¤WµLÃþ¦üµL¨x¬r©Ê¤§Ävª§ÃĪ«½Æ¤è

2.½Æ¤è¤w¥Ñ¬ü°êFDA­n¨D­°¾¯¶q§C©ó325²@§J¡A±N¼vÅTÀø®Ä

3.¦³¨Ï¥Î±M§Q¡A¥i­×§ï©Î§R°£FDA¨x¬rĵ»y

4.¥i¼W¥[¤AñQÓi×ô¾¯¶q

¡]¥Ñ325mg ¦^´_¦Ü500 mg¬Æ¦Ü§ó°ª¡A·|¸û¦³®Ä¡^¥H¼W¥[Àø®Ä¡A©Î´î¤ÖOpioids¾¯¶q¡A­°§C¦¨Å}°Æ§@¥Î

5.¤GªÌ¾Ü¤@±ÂÅv

6.¥i¼W¥[¥«¦û²v

¬ãµo¶¥¬q:

1.SNP-810¨ú±oÃÄÃÒ«á¡A¶i¦æÁ{§É¸ÕÅç§t¬Ûµ¥©Ê¸ÕÅç

SNP-830 ¤£¬O ·s¦¨¤À ªº·sÃÄ¡A©Ò¥H¤£»Ý­n¶i¦æ²Ä¤@¡A¤G¤Î¤T´ÁÁ{§É´úÅç

µ¥ SNP-810 ®³¨ìÃÄÃÒ«á¡A¥H ·sÀø®Ä½Æ¤è¶i¦æÁ{§É¸ÕÅç§t¬Ûµ¥©Ê´úÅç ´N¥i¥HÀò±oÃÄÃÒ

=============================================================================

*****************************************************************************

SNP-8 ¨t¦C Àø®Ä¤ÀªR¡G

1. ¦b°Êª«¤W¥H¤£¦P¾¯¶q¶i¦æ¸ÕÅç¡Aµ²ªGÅã¥Ü p<0.005

1. ¤w¸g§¹¦¨¤§¤HÅé¸ÕÅç¡Aµ²ªGÅã¥Ü p<0.005

=============================================================================

*****************************************************************************

¥¼¨Ó¥Ø¼Ð±ÂÅv¥D¤O²£«~¡G

1. ¯×ªÕ¨xÃÄ¡GSNP-610 ©M SNP-630 ¦U¦³ÀuÂI¡A¥Ø¼Ð¬°¥þ²y±ÂÅv

2. ¤îµhÃÄ(OTC): SNP-810, ¥Ø¼Ð¬°¬ü°ê¤Î¥þ²y±ÂÅv

3. ¤îµhÃÄ(³B¤èÃÄ): SNP-830 ¤Î SNP-840, ¦b°Êª«¤W¬Ò¦³¥¿­±ªºµ²ªG¡A¥Ø¼Ð¬°¥þ²y±ÂÅv

=============================================================================

*****************************************************************************

¥Ø«e¤½¥q»P°ê»Ú¤j«¬Ãļt¥¿¦b½Í§Þ³N±ÂÅv©M¦X§@­p¹º

§Ú¬Ý¹L¤½¥q©xºô©M©Ò´£¨Ñªº¸ê®Æ¡Aı±o¤½¥q«Ü¥Î¤ß¦b¸gÀç¡A¦Ó¥B¸ê®Æ¤]«Ü¸Ô²Ó

¹ï¤½¥qµo®i«Ü¦³¦Û«H¡A¥¼¨ÓªÑ»ù­È±o´Á«Ý¡A¦³¾÷·|¬O ¤U¤@­Ó ¦X¤@ ÄÆªÑ

-----------------------------------------------------------------------------

¥H¤W¸ê®Æ ³£°Ñ¦Ò ªÑªF·|ij¨Æ¿ý.pdf ©M ¤½¥q©xºô (¦³¿³½ìµÛÅwªï¦A²`¤J¬ã¨s»P°Q½×)

·|­û:ROGER588910148151µoªí®É¶¡:2024/7/11 ¤W¤È 06:18:18²Ä3902½g¦^À³
¥ÌÅS¾J(§l¤J°ªº¯³zÀ£ÃÄ«~400mg)µ²ºc²³æªº¤p¤À¤l-§ïµ½Ån©ÊÅÖºû¤Æ±wªÌªºªÍ¥\¯à!

1.2005¦~11¤ë7¤é¡A¼Ú·ù©e­û·|±Â¤©·ç¨åStricent AB¥Î©óªvÀøÅn©ÊÅÖºû¤Æªº¥ÌÅS¾Jªº©t¨àÃĺٸ¹¡]EU/3/05/325¡^¡C

¦Û 2012 ¦~ 4 ¤ë 13 ¤é°_¡A¥ÌÅS¾J¦b¼Ú·ù³Q±ÂÅv¬° ¤ä®ðºÞ¾J

¦b 2011 ¦~ 11 ¤ë 8 ¤é¦Ü 9 ¤éªº·|ij¤W¡A©t¨àÃÄ©e­û·|( COMP ) ¼f¬d¤F±N Bronchitol¡]¥ÌÅS¾J¡A¥H«eºÙ¬°¥ÌÅS¿}

¾J¡^§@¬°ªvÀøÅn©ÊÅÖºû¤Æªº©t¨àÃĪº»{©wEU/3/ 05/325 ¡C

www.ema.europa.eu/en/medicines/human/orphan-designations/eu-3-05-325

2.2020.5.1-§l¤J¥ÌÅS¾JªvÀøÅn©ÊÅÖºû¤Æ

www.ncbi.nlm.nih.gov/pmc/articles/PMC7195814/

¥ÌÅS¾J¥i¼W¥[ÂH½¤ÅÖ¤ò²M°£²v¡A¦ý¨ä [½T¤Á§@¥Î¾÷Âà©|¤£²M·¡]¡C»P»Ý­n³z¹L¼QÃú¾¹»¼°eªº²{¦³»s¾¯¬Û¤ñ¡A¥ÌÅS¾Jªº°®¯»»s

¾¯¥i¯à§ó¤è«K¥B§ó®e©ö¨Ï¥Î¡C§l¤J°®¯»¥ÌÅS¾JªvÀøÅn©ÊÅÖºû¤Æªº III ´Á¸ÕÅç¤w¸g§¹¦¨¡A²{¤w¦b¿D¬w©M¼Ú¬w¤@¨Ç°ê®a¤W¥«¡C

³o¬O¤§«eµû½×ªº§ó·s¡C

3.2020.11.2-Chiesi «Å¥¬ FDA §å­ã Bronchitol®¡]¥ÌÅS¾J¡^§l¤J¯»¥½

----------------------------------------------------------------------------------------------

µ¥«Ý¤fªA400mg¥ÌÅS¾J+400mg¤T´â½©¿}¦bMASH»P¿}§¿¯f¤j©ñ¥ú©ú!!!

·|­û:ROGER588910148151µoªí®É¶¡:2024/7/10 ¤U¤È 07:28:56²Ä3901½g¦^À³
·|­û¡GROGER588910148151 µoªí®É¶¡:2024/7/2 ¤W¤È 09:36:35²Ä 3870 ½g¦^À³

2024.2.20-­P©Rªº¯×ªÕ¡G¯ØÅ¦¤º¯×½è¾É­P¯ØÅ¦Àù

¦b©s¼wº¸ÀH¾÷¤Æ©M«e¤©Ê¶¤¦C¬ã¨s¤¤¡A1¯ØÅ¦¤º¯×ªÕ·|¼W¥[¯ØÅ¦Àùªº­·ÀI¡C³o¬°¯×½è»P¯ØÅ¦Àù¯g¤§¶¡ªº¦]ªGÃö«Y´£¨Ñ¤F¦³»¡ªA¤Oªº¤HÃþÃÒ¾Ú¡A[ÃÒ¹ê¤F¼ï¦·©Ô°²»¡ªº¹w´ú]¡C

---------------------------------------------------------------------------------------------------

¯ØÅ¦­P©Rªº¯×ªÕ--2«¬¿}§¿¯f»P¡uÀù¤ý¡v¯ØÅ¦Àù

[©s¼wº¸ÀH¾÷¤Æ]³Q»{¬°Ãþ¦ü©ó¡u¦ÛµMªºÀH¾÷¹ï·Ó¸ÕÅç¡v---¦]ªGÃö«Y¬OÅKÃÒ¦p¤sµL¥iÅG»é!

·|­û:ROGER588910148151µoªí®É¶¡:2024/7/10 ¤U¤È 07:08:30²Ä3900½g¦^À³
·|­û¡GROGER588910148151 µoªí®É¶¡:2024/7/10 ¤U¤È 04:31:01²Ä 3898 ½g¦^À³

³z¹L´î¤Ö¯ØÅ¦¯×ªÕ°fÂà²Ä 2 «¬¿}§¿¯f(¬ã¨s¤H­ûªí©ú¡A³z¹L´îªÎ´î¤Ö¤£¨ì¤@§Jªº¯×ªÕ¥i¥H°fÂà¿}§¿¯f)

--------------------------------------------------------------------------------------------------

·|­û¡GROGER588910148151 µoªí®É¶¡:2024/6/17 ¤U¤È 05:02:07²Ä 3830 ½g¦^À³

¥ÌÅS¾J+¤T´â½©¿}ªº¾÷¨î???

2024 ¦~ Rolf Luft ¼ú

-------------------------------------------------------------------------------------------------

SNP-6§¹³Æ2¦ì¿}§¿¯fÅv«Â»¡ªº°fÂà¾÷¨î!!!

·|­û:ROGER588910148151µoªí®É¶¡:2024/7/10 ¤U¤È 06:54:00²Ä3899½g¦^À³
Professor roy taylor¬O¯Ã¥d´µº¸¤j¾ÇÂå¾Ç©M¥NÁ¾ǺaÅA±Ð±Â ¡A¤]¬O­^°ê¿}§¿¯f°òª÷·|¸ê§Uªº¬ã¨s­û¡C

¦]¨ä¹ï¿}§¿¯f¬ã¨sªº°^Äm¦ÓºaÀòMBE

2023.1.6- www.diabetes.org.uk/about-us/news-and-views/professor-roy-taylor-awarded-mbe-services-diabetes-research

--------------------------------------------------------------------------------------------------

¤@³õ½w¸Ñ­²©R

®õ°Ç±Ð±Â«á¨Óªº¬ã¨s¶i¤@¨B´¦¥Ü¤F 2 «¬¿}§¿¯f¬O¦p¦óµo®iªº¡A¥H¤Î¦p¦óÅý¯ØÅ¦¦A¦¸¤u§@¥H¨Ï²Ä 2 «¬¿}§¿¯f½w¸Ñ¡C

¦Û 2008 ¦~¥H¨Ó¡A§Ú­Ì¤@ª½¤ä«ù®õ°Ç±Ð±Âªº¶}³Ð©Ê½w¸Ñ¬ã¨s¡C¦ý®õ°Ç±Ð±Âªºµo²{§ï¼g¤F²Ä 2 «¬¿}§¿¯fªº¬G¨Æ¡C

¨ì 2011 ¦~¡A¥Lªº¬ã¨sµ²ªGªí©ú¡A¤@¨Ç 2 «¬¿}§¿¯f±wªÌ¥i¥H³z¹L§C¼ö¶q¶¼­¹Åé­«ºÞ²z­pµe´î»´Åé­«¡A±q¦ÓÀò±o½w¸Ñ¡C¥L¶}µo¤F³Ð·sªº¬ã¨s§Þ³N¡A³o·N¨ýµÛ§Ú­Ì¥i¥H©çÄá¨xŦ©M¯ØÅ¦µ¥¾¹©x¤º³¡©M©P³òªº¯×ªÕ¤ô¥­¹Ï¹³¡C

¥Lªº¥@¬É­º³Ðµ²ªGªí©ú¡A´î¤Ö¨xŦ©M¯ØÅ¦¤º¦h¾lªº¯×ªÕ¬O½w¸Ñ¯f±¡ªºÃöÁä¡C

¥Lªº¥@¬É­º³Ðµ²ªGªí©ú¡A´î¤Ö¨xŦ©M¯ØÅ¦¤º¦h¾lªº¯×ªÕ¬O½w¸Ñ¯f±¡ªºÃöÁä¡C

¥Lªº¥@¬É­º³Ðµ²ªGªí©ú¡A´î¤Ö¨xŦ©M¯ØÅ¦¤º¦h¾lªº¯×ªÕ¬O½w¸Ñ¯f±¡ªºÃöÁä¡C

·|­û:ROGER588910148151µoªí®É¶¡:2024/7/10 ¤U¤È 04:31:01²Ä3898½g¦^À³
www.sinewpharma.com/Upload/download/20240606-video.MP4

40¤À:¶}µoªvÀø¯×ªÕ[¯Ø]·s¥Î³~·sÃÄ

-----------------------------------------------------------------------------------------

³z¹L´î¤Ö¯ØÅ¦¯×ªÕ°fÂà²Ä 2 «¬¿}§¿¯f(¬ã¨s¤H­ûªí©ú¡A³z¹L´îªÎ´î¤Ö¤£¨ì¤@§Jªº¯×ªÕ¥i¥H°fÂà¿}§¿¯f)

www.ncl.ac.uk/press/articles/archive/2015/12/pancreasstudy/

¥@¬É¿}§¿¯f¤j·|¤Wµoªí¡C¬ã¨s­û®õ°Ç±Ð±Â(Professor Roy Taylor)¦b¤j·|¤W»¡¡G¡u²Ä¤G«¬¿}§¿¯f±wªÌ´î­«¤§«á¡A¥i¥H´î¤Ö¯ØÅ¦ªº¦h¾l¯×ªÕ¡A«P¨Ï¯ØÅ¦¥\¯à«ì´_¥¿±`¡C¦]¦¹¡A¦pªG§A°Ý§Ú¡A¯f¤H»Ý­n´î¤Ö´X¤½¤ç¤~¯à§ïµ½¿}§¿¯f¡Aµª®×´N¬O1¤½§J¡C¤£¹L¡A³o1¤½§J¥²¶·¬O¨Ó¦Û¯ØÅ¦ªº¯×ªÕ¡C¡v

·|­û:ROGER588910148151µoªí®É¶¡:2024/7/10 ¤U¤È 04:21:46²Ä3897½g¦^À³
SNP-610­°§C29.5 U/L(³o¬O¤HÅéÁ{§É¼Æ¾Ú¡A¤£¬O°Êª«¹êÅç¼Æ¾Ú!)

Type 2 diabetes or pre-diabetes

Present, n=18 Not present, n=17

-----------------------------------------------------------------------------------------

§@ªÌ±o¥Xµ²½×¡A¨xŦ¯×ªÕ°ï¿n¥i¯à¬OÂà¤Æ¬°¿}§¿¯fªºÄ²µo¨Æ¥ó¡C¬°¤F¤ä«ù«á¤@ºØ¥i¯à©Ê¡A¤w¸gµo²{[ALT¤É°ª]¬Oµo¥Í 2 «¬¿}§¿¯fªº¦­´Á¦MÀI¦]¯À¡A»PªÎ­D¡BÅé¯×ªÕ¤À§G¡B¦å¿}¡B¦å¯×¡BAST¡BÁx¬õ¯À¿@«×©M®a±Ú¥vµLÃö....

-----------------------------------------------------------------------------------------

·|­û¡GROGER588910148151 µoªí®É¶¡:2024/6/18 ¤U¤È 11:23:36²Ä 3841 ½g¦^À³

www.sinewpharma.com/Upload/202312/news_2023122509345208.pdf

Type 2 diabetes or pre-diabetes

Present, n=18 Not present, n=17

·|­û:ROGER588910148151µoªí®É¶¡:2024/7/10 ¤U¤È 04:12:14²Ä3896½g¦^À³
2024.9.24-²Ä¤K©¡ªi¤h¹yMASHÃĪ«¶}µo°ª®p·|-¦¶¸³¤fÀY³ø§i:

......Also exploring a case study of this in a phase 2 [oral insulin] versus placebo study?

[oral insulin]¤fªA¯Ø®q¯À¡A¿}§¿¯f???

2«¬¿}§¿¯f©MNAFLD ±wªÌªº[ALT¤U­°]»P [¨xŦ¯×ªÕ´î¤Ö] ¦³Ãö....(SNP-610­°§C29.5 U/L)

2«¬¿}§¿¯f©MNAFLD ±wªÌªº[ALT¤U­°]»P [¨xŦ¯×ªÕ´î¤Ö] ¦³Ãö....(SNP-610­°§C29.5 U/L)

2«¬¿}§¿¯f©MNAFLD ±wªÌªº[ALT¤U­°]»P [¨xŦ¯×ªÕ´î¤Ö] ¦³Ãö....(SNP-610­°§C29.5 U/L)

-----------------------------------------------------------------------------------------------

1. 2024.5.17-[2«¬¿}§¿¯fªºªvÀø¼Ò¦¡¬O®É­ÔÂàÅܤF]

www.mdpi.com/1422-0067/25/10/5488#B55-ijms-25-05488

....³oªí©ú²Ä2«¬¿}§¿¯f¡]¥D­n¡^¬O¥Ñ¨xŦ©M¯ØÅ¦¤º¹L¦hªº¯×ªÕ¤Þ°_ªº¡C

....¦]¦¹¡A¦­´Á¹w¨¾/´î¤Ö[¨xŦ]©M[¯ØÅ¦]²§¦ì¯×ªÕ°ï¿n¥i¯à¦¨¬°²Ä¤G«¬¿}§¿¯fºÞ²zªº¥D­nªvÀø¥Ø¼Ð¡C

2.2008.8.26- 2«¬¿}§¿¯fªºµo¯f¾÷Âà¡G°lÂܱqªv¡¨ì¯f¦]ªº¤Ï¦V¸ô®|

link.springer.com/article/10.1007/s00125-008-1116-7

¨xŦ©M¯Ø®q¤¤ªº[²§¦ì¯×ªÕ¨I¿n]¬O¨xŦ¯Ø®q¯À§Ü©Ê©M [£]²Ó­M¥\¯à»Ùê]¬ÛÃö°ÊºA¯Ê³´ªº°ò¦¡C³o¨Ç¯Ê³´¦b§C¯à¶qÁý¾i±ø¥ó¤U¯à°÷ÅãµÛ°fÂà¡A¦b¦­´Á¿}§¿¯f¤¤§¹¥þ°fÂà¡A

--------------------------------------------------------------------------------------------------

·|­û¡GROGER588910148151 µoªí®É¶¡:2023/11/23 ¤U¤È 09:34:59²Ä 3543 ½g¦^À³

ALT ­°§C¶W¹L 17 U/L ¤w³QÃÒ©ú»P NASH ±wªÌªº²Õ´¾Ç¤ÏÀ³¬ÛÃö(ÅÖºû¤Æ§ïµ½)!-->SNP-610­°§C29.5 U/L.

www.ncbi.nlm.nih.gov/pmc/articles/PMC6617813/

¶ø¨©Áx»Ä( InterceptªºOCA)¡B elafibranor©M§Q©Ô¾|肽(¿Õ©M¿Õ¼w)ªº¬ã¨s¤wÃÒ©ú¡A¦bNASHªvÀø¬ÛÃö²Õ´¾Ç§ïµ½©Î®ø°hªº±wªÌ¤¤¡AALT ·|¤U­°¡A¦Ó¥B2«¬¿}§¿¯f©MNAFLD ±wªÌªºALT ¤U­°»P¨xŦ¯×ªÕ´î¤Ö¦³Ãö....

·|­û:ROGER588910148151µoªí®É¶¡:2024/7/10 ¤W¤È 10:08:25²Ä3895½g¦^À³
·|­û¡GROGER588910148151 µoªí®É¶¡:2022/9/1 ¤U¤È 08:52:35²Ä 2370 ½g¦^À³

SNP-810µLµÇ¬r©Ê³o­ÓÀuÂI¡A¹ï©ó·m§ðNSAIDs¡]«DÃþ©T¾J®øª¢¤îµhÃÄ¡^ªº¥«³õ¥÷ÃB¤j¦³§U¤O!

¤îµhÃį}ÃaµÇŦ«OÅ@¾÷¨î!!!

www.commonhealth.com.tw/article/74087

½Ð·V¥Î¤îµhÃÄ¡IµÇŦ¬ì¦WÂå¨Iµh§i¥Õ

------------------------------------------------------------------------------------------------

2024.7.2-¼³¼ö®§µh¹L¶q¾É­P«æ©Ê[µÇ] ·l¶Ë¦ý[µL¨x¬r©Ê]¡G¯f¨Ò³ø§i

intjem.biomedcentral.com/articles/10.1186/s12245-024-00662-w

µ²½×

Á`¤§¡A¼³¼ö®§µh [µÇ¬r©Ê] ¦Ó [¤£¨x¬r©Ê]¨Ã¤£¨u¨£¡A¥BÀ³ºÊ´ú±wªÌ¶W¹L 48 ¦Ü 72 ¤p®É¡C¾¨ºÞ NAC ¦b¨x¬r©Ê¤è­±ªº§@¥Î²³©Ò©Pª¾¡A¦ý¨ä¦b¹w¨¾µÇ¬r©Ê¤è­±ªº§@¥Î©|¥¼±o¨ìÃÒ¹ê¡C

·|­û:ROGER588910148151µoªí®É¶¡:2024/7/9 ¤U¤È 06:42:02²Ä3894½g¦^À³
www.sinewpharma.com/Upload/download/20240606-video.MP4

40¤À:¤îµhÃÄ(«D³B¤èÃÄ)µ¦²¤©Ê¼Ú¬ü¤À¶}±ÂÅv

--------------------------------------------------------------------------

¬°¦ó¤À¶}±ÂÅv?

¥i¯à»P³o¦³Ãö«Y:2023.7.28www.gao.gov/assets/gao-23-106570.pdf ¬ü°êFDA[«D³B¤èÃÄ]¤¤±Æ¥L©Ê±ø´Ú(¥«³õ¿W¦ûÅv)

·|­û:ROGER588910148151µoªí®É¶¡:2024/7/9 ¤U¤È 06:11:11²Ä3893½g¦^À³
1¦~5­¿ªÌ¦p¹L¦¿¤§ÃV¡A5¦~1­¿ªÌ«o¹é­Y¨°¬P!

2024.6.21-½ä¿ùÃä¡I¥x¿n¹q¡u¹H¬ù¥æ³Î2892¸U¡v¡@ºÃ¤Ö¦~ªÑ¯«¤@¤i½ß¥ú

-------------------------------------------------------------------------------

¦~»´¤H²×¨s¬O¦~»´¤H¡A¤Ó½Ä°Ê¤F¡CªÅ¤û®ð¨R¤Ñªº¥xG?

¤£¹L¦~»´¤]¬O¥»¿ú¡A¯d±o«C¤s¦b¤£©È¨S®ã¿N¡A§O§Ñ±Ð°V´N¦n~

·|­û:ROGER588910148151µoªí®É¶¡:2024/7/9 ¤U¤È 05:34:31²Ä3892½g¦^À³
·|­û¡GROGER588910148151 µoªí®É¶¡:2024/5/14 ¤W¤È 08:39:02²Ä 26 ½g¦^À³

....º¡¤j¾÷²v´N¯à¤W¨ì³Ì³»¼h ¡A¦]¦¹(§Ú)Ä~Äò«ù¦³...

--------------------------------------------------------------------------------

...·ç»È¶°¤½¥¬ªº¾ÚÅã¥Ü¡A²b¸ê²£¦b300¸U¨ì3000¸U·s¥x¹ôªº¡u·Ç´I¸Î¼h960¸U¤H¡v¡A¥e¥þ¥x¤H¤f45%¡A±Nªñ¤@¥b...

-------------------------------------------------------------------------------------------------

­Ó¤Hµ²½×:­P´I¤§¹D¡A§Ö´N¬OºC¡AºC´N¬O§Ö¡C(«ùªÑ>12¦~)

·|­û:ROGER588910148151µoªí®É¶¡:2024/7/9 ¤U¤È 05:19:47²Ä3891½g¦^À³
·|­û¡GROGER588910148151 µoªí®É¶¡:2022/1/5 ¤U¤È 04:48:09²Ä 1550 ½g¦^À³

...¼B³Ó«iµªÂЪí¥Ü....P­È¥Ø«eÁÙ¥¼®³¨ì....©Ò¥HµLªk¤½¥¬¡C

¬O¯uª÷´N¤£©È¤õ·Ò¡A¤p´²¤á¤j©È¬Æ? ©ú¤Ñíöt£x.

------------------------------------------------------------------------------------------------

§Ú¬J¬ÝªÅ´N¤£°µ¦h¤]¤£°µªÅ¡A°O¤£²M¬O¨º¦~¼o¤F¿Ä¸ê¨é¸ê®æ¡C

­P´I¤§¹D¡A§Ö´N¬OºC¡AºC´N¬O§Ö¡A[°í«ù¦Û§Ú§PÂ_]¡A±E±x¦Û¤vªº§ë¸ê¸`«µ!

·|­û:ROGER588910148151µoªí®É¶¡:2024/7/9 ¤U¤È 05:06:23²Ä3890½g¦^À³
¡§1¦~5­¿ªÌ¦p¹L¦¿¤§ÃV¡B5¦~1­¿ªÌ«o¹é­Y¨°¬P¡¨(®©¤£¥X? ¦^·Q¤@¤U°ê¹©¿ÄÂ_¤W300.....)

­P´I¤§¹D¡A§Ö´N¬OºC¡AºC´N¬O§Ö¡AµLÄߪi°Ê¡A[°í«ù¦Û§Ú§PÂ_]

-------------------------------------------------------------------------------------------------

·|­û¡GROGER588910148151 µoªí®É¶¡:2024/6/13 ¤U¤È 05:27:50²Ä 3807 ½g¦^À³

¦p¦ó°í¦u¤º¤ßªº¡§§ë¸ê¸`«µ¡¨¡H

ªÑ»ù¤Wº¦®É¿³¾Ä¡A§Ô¤£¦í·Q­n¥[­Ü¡F¤U¶^®É¤S¼~¼{¡A§Ô¤£¦í¤S»°ºò³Î¦×¡A¸¨³U爲¦w¡A©ó¬O¤@º¦´N¶R¡A¤@¶^´N½æªº¦æ爲µL­­´`Àô!

·|­û:dk10140377µoªí®É¶¡:2024/7/9 ¤U¤È 04:19:59²Ä3889½g¦^À³
ª½±µ¶}©ñªÑªFÁʶR¸Õ¥Î~~¯Â¯Âªº¤HÅé¸ÕÅç

¬Ý¬O¤£¬O¦p­Jp»¡ªº³o¦n¡A¶R¤F©ñµÛ¤~¦³«H¤ß

·|­û:dk10140377µoªí®É¶¡:2024/7/9 ¤W¤È 08:46:01²Ä3888½g¦^À³
º©º©ªø¸ô¤¤¡A¬O©Ô¦^ÁÙ¬O³Ì«á¤W¨®¾÷·|?

Â಴Q3­n¨ì¤F¡A³oÀɯu¬O¿\¥ÉÁÙ¬O¥ÛÀY?

·|­û:ROGER588910148151µoªí®É¶¡:2024/7/6 ¤U¤È 11:35:41²Ä3887½g¦^À³
·|­û¡GROGER588910148151 µoªí®É¶¡:2021/2/5 ¤W¤È 06:41:22²Ä 694 ½g¦^À³

¥H²{¦bÃĪ«¤W¥«¼f¬d­ì«h¡AAPAP¬O¤£¥i¯à¦b¬ü°ê»P­^°ê¤W¥«¡C

SNP-810µL¨x¬r·s¾¯«¬·sÃÄ¥¿¬O³Ð·s¦w¥þ§ï­²¡A¯àÀò±o¡m«D³B¤èÃĦw¥þ¡A³Ð·s©M§ï­²ªk®×¡n¤°»ò¿EÀy¹ªÀy???????

2020¦~3¤ë27¤é¤t´¶Ã±¸pªº¡m«D³B¤èÃĦw¥þ¡A³Ð·s©M§ï­²ªk®×¡n´N¬O­n¸Ñ¨M³oÃþÃĪ«ªº°ÝÃD¡C

-----------------------------------------------------------------------------------------------

·|­û¡GROGER588910148151 µoªí®É¶¡:2021/1/4 ¤U¤È 05:35:26²Ä 461 ½g¦^À³

1972¦~FDA¥l¶°¤F¤@²ÕÂå¥Í©M¬ì¾Ç®a¨Óµû¦ô¤îµhÃÄ(¥]¬A¹ï¤A酰®ò°ò×ô)..µ²ªGªá¤F48¦~©|¥¼¸Ñ¨M¨x¬r©Ê¡C Orz.

1. 2012¦~1¤ë24¤é

---FDA¤µ¤Ñ¤£·|§å...¹ï¤A酰®ò°ò×ô(APAP)¤]¬O¤@¼Ë¤£·|§å­ã¡]¦b¬ü°ê¡A¹L¶q¨Ï¥Î¬O¾É­P¨x°IºÜªº¥D­n­ì¦]¡^

Analgesics have a spotty history of switching to OTC. According to common wisdom, the FDA would not approve aspirin today much less allow it to go OTC. The same could be said for acetaminophen (overdose of which is the leading cause of liver failure in the US)

---------------------------------------------------------------------------------------------

¥H²{¦bFDAÃĪ«©Ê¨x·l¶Ë¤W¥««eÁ{§É«ü«n¡AAPAP¹L¤£¤F¨x¬r©ÊªùÂe!

·|­û:ROGER588910148151µoªí®É¶¡:2024/7/6 ¤U¤È 09:51:18²Ä3886½g¦^À³
·sÃĶ}µoªº®Ú¥»:¨ä¥Hªk¥O¨î«×¬°¸g¡B¹êÃÒ¬ì¾Ç(Á{§É¸ÕÅç)¬°½n¡AÁa¾î¥æÂ´¦¨¬ì§Þ»Pªk«ß¥æ¬yªºÀ³¥Î¬ì¾Ç¡C

ÃĪ«¨x·l¶Ë«ü«n¤@Åé¾A¥Î!

FDAÃĪ«©Ê¨x·l¶Ë¤W¥««eÁ{§Éµû¦ô¦æ·~«ü«n

www.fda.gov/media/116737/download

------------------------------------------------------------------------------------------------

·|­û¡GROGER588910148151 µoªí®É¶¡:2024/7/4 ¤W¤È 07:26:47²Ä 3875 ½g¦^À³

1.2024.4.15-¥[¤J £] ²Ó­M¨ë¿EªvÀø[²Ä1«¬]¿}§¿¯fªº¸ÕÅç

¤@¶µ¸ÕÅ祿¦b©Û¶Ò±w¦³²Ä 1 «¬¿}§¿¯fªº¦¨¦~¤H¨Ó¬ã¨s BMF-219¡A³o¬O¤@

2.2024.6.7-FDA ¹ï Biomea Fusion ªº BMF-219 ¿}§¿¯f¸ÕÅç¶i¦æ¥þ­±Á{§ÉÀÁ¸m

¸Ó¨M©w¬O°ò©ó COVALENT-111 ¸ÕÅ礤µo²{ªº¼ç¦bÃĪ«¤Þ°_ªº[¨x¬r©Ê]¤ô¥­¡C

----------------------------------------------------------------------------------------------

·|­û¡GROGER588910148151 µoªí®É¶¡:2024/6/1 ¤U¤È 01:00:55²Ä 3748 ½g¦^À³

µL¨x¬rSNP-810(12g) VS. ¦³¨x¬rAPAP(4g)ªº[¾î¦V¤ñ¸û]:

4.FDA Drug Hepatotoxicity Steering Committee:

.....(ALT) ≥3 times the upper limit of normal (ULN) and ALT/alkaline phosphatase (ALP) ratio ≥5 times ULN; cholestatic DILI by an ALP ≥2 times ULN and ALT/ALP ratio of ≤2 times ULN; and mixed DILI with ALT ≥3 times ULN, ALP ≥2 times ULN and ALT/ALP ratio <5 but >2 times ULN

¨x·l®`¤@¯ë©w¸q«üALT¶W¹L¥¿±`數­È¤W­­ªº3­¿¥H¤W¡A§Y¶W¹L>3­¿³q±`³Q»{¬°¨ã¦³Á{§É·N¸q¡C

·|­û:ROGER588910148151µoªí®É¶¡:2024/7/5 ¤U¤È 06:40:25²Ä3885½g¦^À³
1.[T1R3©MCaSR]¿}±Ó·P¨üÅé¦b¯ØÅ¦ £] ²Ó­Mªº²Ó­Mªí­±ªí¹F-->¤T´â½©¿}¬OT1R3¿E¬¡¾¯--¥i¯à«P¶i¯Ø¸¢£]²Ó­Mªº·s³¯¥NÁ¡C

2.¤T´â½©¿}[§í¨îCD4+ CD8+ T ²Ó­M¼W´Þ]

­ì¥»§ë¸êªYÄ£ªºÃöª`ÂI¡AÀ£®Ú¨S¬ÝªvÀø¿}§¿¯f³o¶ô¡A¤µ¤Ñ¯u¬O¡m¬ü¦nªº·N¥~¡n¡C

--------------------------------------------------------------------------------------------------

2024.9.24-²Ä¤K©¡ªi¤h¹yMASHÃĪ«¶}µo°ª®p·|-¦¶¸³¤fÀY³ø§i:

......Also exploring a case study of this in a phase 2 [oral insulin] versus placebo study?

[oral insulin]¤fªA¯Ø®q¯À¡A¿}§¿¯f???

·|­û:ROGER588910148151µoªí®É¶¡:2024/7/5 ¤U¤È 05:46:20²Ä3884½g¦^À³
­^°ê¦P¦æ¥h¦~µoªíªº[¤T´â½©¿}]¾÷¨îÀ°¤FªYÄ£¤j¦£!!!

°ª¿@«×ªº¤T´â½©¿}¥i¯à¾É­PPLC-£^1»P(¬¡¤Æªº¡^T²Ó­M¨üÅ骺ªÅ¶¡¶ZÂ÷§ó¤j¡A±q¦Ó¤¤Â_°T¸¹¶Ç¿é¡A[§í¨îCD4+ CD8+ T ²Ó­M¼W´Þ]

2017.8.1-[1«¬¿}§¿¯f]¤¤ªº¦Û¨­¤ÏÀ³©Ê T ²Ó­M www.jci.org/articles/view/94549

§Ú­Ì¹ï¤HÃþT1Dªº²z¸Ñ¤¤¡A[£]²Ó­M]ªº¯}Ãa¥D­n¬O¥Ñ§K¬Ì¤ÏÀ³ªº¾AÀ³©ÊÁuªº[CD4 +©MCD8 + T²Ó­M] ÅX°Êªº§K¬Ì§ðÀ»¤Þ°_ªº

-------------------------------------------------------------------------------------------------

·|­û¡GROGER588910148151 µoªí®É¶¡:2024/6/24 ¤U¤È 06:33:18²Ä 3850 ½g¦^À³

¦A¬Ý¤@¦¸¥h¦~ªº[1«¬¿}§¿¯f]ªº¹Ú¦³¦h¤j!

·|­û:ROGER588910148151µoªí®É¶¡:2024/7/5 ¤W¤È 08:29:16²Ä3883½g¦^À³
www.sinewpharma.com/Upload/download/20240606-video.MP4

40¤À:¶}µoªvÀø¯×ªÕ[¯Ø]·s¥Î³~·sÃÄ

µ²½×:±q¶}µoªvÀø¯×ªÕ[¯Ø]·s¥Î³~·sÃÄ¡A8¦¨´N¬O¦³ÅãµÛ¼Æ¾Ú¬°¨Ì¾Ú!

----------------------------------------------------------------------------------------------

2011.6.9--2«¬¿}§¿¯fªº°fÂà¡G£] ²Ó­M¥\¯à¥¿±`¤Æ»P¯ØÅ¦©M¨xŦ¤T»Ä¥Ìªoà­´î¤Ö¦³Ãö

link.springer.com/article/10.1007/s00125-011-2204-7

¥Ø«eªº¼Æ¾Ú´£¨Ñ¤F©ú½TªºÃÒ¾Ú¡A

Åã¥Ü¯ØÅ¦Á`¯×ªÕªº´î¤Ö»P[£]²Ó­M¥\¯àªº«ì´_]¦³Ãö¡C

Åã¥Ü¯ØÅ¦Á`¯×ªÕªº´î¤Ö»P[£]²Ó­M¥\¯àªº«ì´_]¦³Ãö¡C

Åã¥Ü¯ØÅ¦Á`¯×ªÕªº´î¤Ö»P[£]²Ó­M¥\¯àªº«ì´_]¦³Ãö¡C

·|­û:ROGER588910148151µoªí®É¶¡:2024/7/5 ¤W¤È 07:59:17²Ä3882½g¦^À³
¹ê²{¯u¥¿ªº¿}§¿¯f[ªv¡]¨ú¨M©ó«ì´_¥\¯à©Ê£]²Ó­M½è¶q!!!

¦Ó­«¤¤¤§­«©Î³\¦bT1R3 ¯Ê¥¢-->[Âù¬Û]¯Ø®q¯À¤Àªc¨ü¨ìÅãµÛ§í¨î!!!

------------------------------------------------------------------------------------

2024.1.26--¥\¯à²§½è©Ê£]²Ó­M½Õ¸` [Âù¬Û] [Âù¬Û] [Âù¬Û]¯Ø®q¯À¤Àªc

www.nature.com/articles/s42255-023-00964-y

...§Ú­Ì¶i¤@¨Bªí©ú¡ARR£]s ªº¥\¯à»Ùê¦b¿}§¿¯fªº¶i®i¤¤°_µÛ¦ÜÃö­«­nªº§@¥Î¡C

·|­û:ROGER588910148151µoªí®É¶¡:2024/7/5 ¤W¤È 07:21:51²Ä3881½g¦^À³
·|­û¡GROGER588910148151 µoªí®É¶¡:2024/7/4 ¤U¤È 09:31:10²Ä 3878 ½g¦^À³

2017.9.17-[¸²µå¿}±Ó·P¨üÅé] ¦b¯Ø®q¯À¤Àªc¤¤ªº§@¥Î

µL½×¦p¦ó

T1R3 ªºªí¹F¦bªÎ­D©M¿}§¿¯f¤¤[­°§C]¡C½T©w¦b¤HÃþªÎ­D©Î¿}§¿¯f¤¤¬O§_Æ[¹î¨ìÃþ¦üªºªí¹FÅܤƱN¬O«Ü¦³½ìªº¡C

---------------------------------------------------------------------------------------------

2005.3.1-«C¤Ö¦~²Ä 2 «¬¿}§¿¯f¡G¯Ø®q¯À§Ü©Ê¡B£] ²Ó­M°IºÜ¡A©Î¨âªÌ­Ý¨ã¡H

diabetesjournals.org/care/article/28/3/638/27718/Youth-Type-2-DiabetesInsulin-resistance-cell

µ²½×

³o¬O²Ä¤@¶µ°w¹ï«C¤Ö¦~ªº¬ã¨s¡AÅã¥Ü»P¬Û¤Ç°tªºªÎ­D¹ï·Ó¨ü¸ÕªÌ¬Û¤ñ¡A±w¦³²Ä 2 «¬¿}§¿¯fªº«C¤Ö¦~ªº¯Ø®q¯À±Ó·P©Ê©M¯Ø®q¯À¤Àªc§¡¨ü·l...¦ý¥O¤H¤£¦wªºÆ[¹îµ²ªG¬O¦b«Ü¤pªº®É­Ô¯Ø®q¯À¤Àªc´NÄY­«¨ü·l¡]FPIS ­°§C¬ù75%¡FSPIS ­°§C¬ù50 %¡^¿}§¿¯f¯fµ{¬Û¹ï¸ûµu¡C³o¨Çµo²{ªº·N¸q¥i¯à¬O¦­´Á»Ý­n¯Ø®q¯À´À¥NÀøªk¨Óºû«ù¦å¿}±±¨î¡C

­Ó¤Hµ²½×:2005¦~¡]FPIS ­°§C¬ù75%¡FSPIS ­°§C¬ù50 %¡^?µª®×À³¸Ó¬O2017¦~£]²Ó­MªºT1R3¯Ê¥¢(FPIS»PSPIS³£¨ü¨ìÅãµÛ§í¨î!!!)

·|­û:ROGER588910148151µoªí®É¶¡:2024/7/5 ¤W¤È 06:21:39²Ä3880½g¦^À³
£]²Ó­M·s¥Í¡G¬@±Ï¿}§¿¯fªº[«á°_¤§¨q]<---->SNP-6(¥ÌÅS¾J+¤T´â½©¿})ªºÃIJz¾÷¨î©Î³\¯uªº¤@À»§Y¤¤!?

¦A¬Ý¤@¦¸¦P¦æªº(¤T´â½©¿}T1R3¿E¬¡¾¯)¬ã¨s:

1.2024.5.21-¤G¤Q¦~¬ã¨s¡G²¢¨ý¨üÊ^¼v响¤HÊ^¥N谢¸²µå¿}ªº¤è¦¡

¥L们发现¡A将TAS1R2-TAS1R3¿E动剂(¤T´â½©¿})

2.Nature¥D¥Z¿¯­¹²¢¨ý¾¯[¤T´â½©¿}]¬O T ²Ó­M¤¶¾É¤ÏÀ³ªº­t½Õ¸`¾¯

3.2.¤T´â½©¿}³Q½T©w¬°¯Ø¸¢£]²Ó­M©MT1R3²¢¨ý¨üÅ骺¿E¬¡¾¯

www.e-enm.org/journal/view.php?doi=10.3803/EnM.2014.29.1.12

4..........

5..........

·|­û:ROGER588910148151µoªí®É¶¡:2024/7/5 ¤W¤È 06:08:02²Ä3879½g¦^À³
SNP-6(¥ÌÅS¾J+¤T´â½©¿})ªºÃIJz¾÷¨î©Î³\¯uªº¤@À»§Y¤¤!?

§ó­«­nªº¬O¡A¦b [T1R3¯Ê¥¢] [T1R3¯Ê¥¢] [T1R3¯Ê¥¢]ªº¯Ø®q¤¤¡A

¯Ø®q¯À¤Àªcªº¨â­Ó¶¥¬q: ²Ä¤@¬Û¯Ø®q¯ÀÄÀ©ñ(FPIS)»P²Ä¤G¬Û¯Ø®q¯ÀÄÀ©ñ(SPIS)³£¨ü¨ì[ÅãµÛ§í¨î]!!!

³Ì¨Î¦å¿}±±¨î»Ý­n²Ä¤@¬Û©M²Ä¤G¬Û¯Ø®q¯ÀÄÀ©ñ¡C

³Ì¨Î¦å¿}±±¨î»Ý­n²Ä¤@¬Û©M²Ä¤G¬Û¯Ø®q¯ÀÄÀ©ñ¡C

³Ì¨Î¦å¿}±±¨î»Ý­n²Ä¤@¬Û©M²Ä¤G¬Û¯Ø®q¯ÀÄÀ©ñ¡C

FPISÄÀ©ñ¹ï©ó¹ï§Ü¤É¿}¯À¹ï¸²µå¿}²£¥Íªº [§Ö³t] ¼vÅT«Ü­«­n¡A¦ÓSPISÄÀ©ñ¹ï©ó [ºû«ù] ³oºØ§í¨î¨Ã¼W¥[¸²µå¿}§Q¥Î²v«Ü

­«­n¡C¯Ê¥FFPISÄÀ©ñ·|¾É­Pµu¼È¡]2¤p®É¡^©M¤¤«×¡]20-30 mg/dl¡^¦å¿}¯Ê³´¡A¦Ó¯Ê¥FSPISÄÀ©ñ·|¾É­Pªø´Á¥B¼@¯P¡]70-100

mg/dl¡^¦å¿}¯Ê³´¡C

------------------------------------------------------------------------------------------------

1.2024.1.26--¥\¯à²§½è©Ê£]²Ó­M½Õ¸` [Âù¬Û] [Âù¬Û] [Âù¬Û]¯Ø®q¯À¤Àªc

www.nature.com/articles/s42255-023-00964-y

µo²{©ö©óÄÀ©ñªº £] ²Ó­M¡]RR£]¡^¬O¹ïÂù¬Û¸²µå¿}¨ë¿Eªº¯Ø®q¯À¤Àªc¦³¤£¦¨¤ñ¨Ò°^Ämªº¨È¸s¡C§Ú­Ì¶i¤@¨Bªí©ú¡ARR£]s ªº¥\¯à»Ùê¦b¿}§¿¯fªº¶i®i¤¤°_µÛ¦ÜÃö­«­nªº§@¥Î¡C

2.2023.2.27-²Ä¤@¬Û¯Ø®q¯À¤Àªc¡G¨äµû¦ô¯à§_«ü¾ÉªvÀø¤èªk¡H

www.sciencedirect.com/science/article/pii/S1043276023000309

...§Ú­Ì®i¥Ü¤F²Ä¤@¬Û¯Ø®q¯À¤Àªc»P¸²µå¿}íºAªº¬ÛÃö©Ê¡A¨Ã¤ÀªR¤F¨ä´î¤Ö¹ïÁ{§Éªí²{¡]¯S§O¬OÀ\«á°ª¦å¿}¡^©M¯e¯fµ²ªGªº

¼vÅT¡C¦b³oºØ±¡ªp¤U¡A«ì´_ £] ²Ó­M¥\¯à¥i¯à·|¦¨¬°¹w¨¾©MªvÀø¿}§¿¯fªº¹CÀ¸³W«h§ïÅܪÌ

¦b³oºØ±¡ªp¤U¡A«ì´_ £] ²Ó­M¥\¯à¥i¯à·|¦¨¬°¹w¨¾©MªvÀø¿}§¿¯fªº¹CÀ¸³W«h§ïÅܪÌ

¦b³oºØ±¡ªp¤U¡A«ì´_ £] ²Ó­M¥\¯à¥i¯à·|¦¨¬°¹w¨¾©MªvÀø¿}§¿¯fªº¹CÀ¸³W«h§ïÅܪ̡A

·|­û:ROGER588910148151µoªí®É¶¡:2024/7/4 ¤U¤È 09:31:10²Ä3878½g¦^À³
2017.9.17-[¸²µå¿}±Ó·P¨üÅé] ¦b¯Ø®q¯À¤Àªc¤¤ªº§@¥Î

dom-pubs.pericles-prod.literatumonline.com/doi/10.1111/dom.13013

³o¨Çµ²ªGªí©ú[T1R3©MCaSR]ªº²§¤G»EÅé¬O [¸²µå¿}±Ó·P¨üÅé]ªº¥D­n¦¨¤À¡C

...

·í´ú¶q±q T1R3 ºV°£¤p¹«Àò±oªº¯Ø®q¤¤ªº¯Ø®q¯À¤Àªc®É¡A»P¥¿±`¤p¹«ªº¯Ø®q¬Û¤ñ¡A¸²µå¿}»¤¾Éªº¯Ø®q¯À¤Àªc³Q§í¨î¬ù 40%¡C§ó­«­nªº¬O¡A¦bT1R3¯Ê¥¢ªº¯Ø®q¤¤¡A¯Ø®q¯À¤Àªcªº²Ä¤@¶¥¬q©M²Ä¤G¶¥¬q³£¨ü¨ìÅãµÛ§í¨î

..µL½×¦p¦ó

T1R3 ªºªí¹F¦bªÎ­D©M¿}§¿¯f¤¤[­°§C]¡C½T©w¦b¤HÃþªÎ­D©Î¿}§¿¯f¤¤¬O§_Æ[¹î¨ìÃþ¦üªºªí¹FÅܤƱN¬O«Ü¦³½ìªº¡C

T1R3 ªºªí¹F¦bªÎ­D©M¿}§¿¯f¤¤[­°§C]¡C½T©w¦b¤HÃþªÎ­D©Î¿}§¿¯f¤¤¬O§_Æ[¹î¨ìÃþ¦üªºªí¹FÅܤƱN¬O«Ü¦³½ìªº¡C

T1R3 ªºªí¹F¦bªÎ­D©M¿}§¿¯f¤¤[­°§C]¡C½T©w¦b¤HÃþªÎ­D©Î¿}§¿¯f¤¤¬O§_Æ[¹î¨ìÃþ¦üªºªí¹FÅܤƱN¬O«Ü¦³½ìªº¡C

-----------------------------------------------------------------------------------------

(¤T´â½©¿}³Q½T©w¬°[¯Ø¸¢£]²Ó­M] ©MT1R3²¢¨ý¨üÅ骺¿E¬¡¾¯)

2024.9.24-²Ä¤K©¡ªi¤h¹yMASHÃĪ«¶}µo°ª®p·|-¦¶¸³¤fÀY³ø§i:

......Also exploring a case study of this in a phase 2 [oral insulin] versus placebo study?

À³¸Ó«Ü¦³½ìªº!

·|­û:ROGER588910148151µoªí®É¶¡:2024/7/4 ¤U¤È 09:23:01²Ä3877½g¦^À³
SNP-6(¥ÌÅS¾J+¤T´â½©¿})ªºÃIJz¾÷¨î©Î³\¯uªº¤@À»§Y¤¤!?

(¤T´â½©¿}³Q½T©w¬°[¯Ø¸¢£]²Ó­M] ©MT1R3²¢¨ý¨üÅ骺¿E¬¡¾¯)

1.2024.5.21-¤G¤Q¦~¬ã¨s¡G²¢¨ý¨üÊ^¼v响¤HÊ^¥N谢¸²µå¿}ªº¤è¦¡

m.ebiotrade.com/newsf/2024-5/20240518052435596.htm

¥L们发现¡A将TAS1R2-TAS1R3¿E动剂(¤T´â½©¿}¡A¤@Ïú¹s热¶q²¢¨ý剂)©ÎTAS1R2-TAS1R3«ú§Ü剂(¨Å»Äà­¡A¤@Ïú§í¨î²¢¨ýªº钠盐)ÉO¸²µå¿}²V¦X¡A会¥H¤£¦Pªº¤è¦¡剧¯P§ï变¤HÊ^ªº¸²µå¿}­@¶q¡C

¤@个¤Hªº°·±d状úGÉO¨äTAS1R2-TAS1R3¨üÊ^ªº¬¡©Ê¤§间¬O§_¦s¦b关¨t?该¬ã¨sªº§@ªÌ说¡A¡§¥i¯à¡¨¡A这ªí©ú¨üÊ^¿E¬¡ªºµ{«×对¦å¿}©M¯Ø岛¯À¤ô¥­¤Î¨ä发¯f时间¦³严­«¼v响¡A这对¥N谢°·±d«Ü­«­n¡C

2.2024.5.18-¿}§¿¯f¡A¦Þ¦y¤Wªºªv·U¡C²¢¨ý¨üÊ^¬O关键吗¡H

zh-cn.futuroprossimo.it/2024/05/diabete-la-cura-sulla-punta-della-lingua-la-chiave-e-il-recettore-del-dolce/

·|­û:ROGER588910148151µoªí®É¶¡:2024/7/4 ¤W¤È 09:32:23²Ä3876½g¦^À³
¿}§¿¯f·s[¶t]©À!!!

1.2024.3.20-¿}§¿¯f¤¤±w¯fªº £] ²Ó­M¡G«æ¶E«Ç¤§®Èªº¨£¸Ñ¡G2023 ¦~³Ç¥X¬ì¾Ç¦¨´N¼úÁ¿®y

2.2009¦~-¯ØÅ¦ £] ²Ó­M¤¤ªí¹Fªº²¢¨ý¨üÅé·|¬¡¤Æ¶t©MÀô AMP °T¸¹¨t²Î¨Ã¨ë¿E¯Ø®q¯À¤Àªc

journals.plos.org/plosone/article?id=10.1371/journal.pone.0005106

¤T´â½©¿}¹ï [Ca 2+ ] c©M [cAMP] cªº¼vÅT¡C

-----------------------------------------------------------------------------------

2½g¬ã¨s°Â¦b¤@¶ô¡A·Q¤@¤USNP-6(¥ÌÅS¾J+¤T´â½©¿})ªºÃIJz¾÷¨î???

·|­û:ROGER588910148151µoªí®É¶¡:2024/7/4 ¤W¤È 07:26:47²Ä3875½g¦^À³
1.2024.4.15-¥[¤J £] ²Ó­M¨ë¿EªvÀø[²Ä1«¬]¿}§¿¯fªº¸ÕÅç

¤@¶µ¸ÕÅ祿¦b©Û¶Ò±w¦³²Ä 1 «¬¿}§¿¯fªº¦¨¦~¤H¨Ó¬ã¨s BMF-219¡A³o¬O¤@ºØ¨ë¿E £] ²Ó­M¥Íªøªº·s«¬¤fªAÃĪ«¡C¸ÓÃĪ«¤w¦b

[²Ä2«¬]¿}§¿¯fªvÀø¤¤Åã¥Ü¥X¥i³ßªº®ÄªG¡A¥i§ïµ½½d³ò®É¶¡©M¦å¿}±±¨î¡C

2.2024.6.7-FDA ¹ï Biomea Fusion ªº BMF-219 ¿}§¿¯f¸ÕÅç¶i¦æ¥þ­±Á{§ÉÀÁ¸m

¸Ó¨M©w¬O°ò©ó COVALENT-111 ¸ÕÅ礤µo²{ªº¼ç¦bÃĪ«¤Þ°_ªº[¨x¬r©Ê]¤ô¥­¡C

------------------------------------------------------------------------------------------

¤p¤À¤lÃÄ¥\¯à©Êªv¡1«¬»P2«¬¿}§¿¯fªºÁ{§É¸ÕÅç¡A­º§å2¦W1«¬¿}§¿¯f±wªÌ£]细­M¥\¯à±o¨ì§ïµ½¡A¦³®Ä¦ý¦]¬°[¨x¬r©Ê]À³¸Ó¬O¨SÀ¸¤F!

·|­û:ROGER588910148151µoªí®É¶¡:2024/7/4 ¤W¤È 07:10:50²Ä3874½g¦^À³
2024.9.24-²Ä¤K©¡ªi¤h¹yMASHÃĪ«¶}µo°ª®p·|-¦¶¸³¤fÀY³ø§i:

......Also exploring a case study of this in a phase 2 [oral insulin] versus placebo study?

-------------------------------------------------------------------------------------------------

www.sinewpharma.com/Upload/download/20240606-video.MP4

40¤À:¶}µoªvÀø¯×ªÕ[¯Ø]·s¥Î³~·sÃÄ

µ²½×:±q¶}µoªvÀø¯×ªÕ[¯Ø]·s¥Î³~·sÃÄ¡A8¦¨´N¬O¦³ÅãµÛ¼Æ¾Ú¬°¨Ì¾Ú!

·|­û:ROGER588910148151µoªí®É¶¡:2024/7/4 ¤W¤È 06:57:58²Ä3873½g¦^À³
2024.9.24-²Ä¤K©¡ªi¤h¹yMASHÃĪ«¶}µo°ª®p·|-¦¶¸³¤fÀY³ø§i:

......Also exploring a case study of this in a phase 2 [oral insulin] versus placebo study?

[oral insulin]¤fªA¯Ø®q¯À¡A¿}§¿¯f???

-----------------------------------------------------------------------------------------------

[oral insulin]¤fªA¯Ø®q¯À--->¿}§¿¯f·s[¶t]©À???

ª`·N¤£¬O²Ó­M»P°Êª«¹êÅç¡A¦Ó¬O¤HÅéÁ{§É¸ÕÅç¼Æ¾Ú!!!

·|­û:ROGER588910148151µoªí®É¶¡:2024/7/4 ¤W¤È 06:44:13²Ä3872½g¦^À³
2023.10.13-£]²Ó­M·s¥Í¡G¬@±Ï¿}§¿¯fªº«á°_¤§¨q!!!

www.sciencedirect.com/science/article/pii/S2090123223003120

-----------------------------------------------------------------------------------------

¤T´â½©¿}³Q½T©w¬°[¯Ø¸¢£]²Ó­M] ©MT1R3²¢¨ý¨üÅ骺¿E¬¡¾¯

·|­û:ROGER588910148151µoªí®É¶¡:2024/7/4 ¤W¤È 06:31:33²Ä3871½g¦^À³
¿}§¿¯f·s[¶t]©À!!!

2024.3.20-¿}§¿¯f¤¤±w¯fªº £] ²Ó­M¡G«æ¶E«Ç¤§®Èªº¨£¸Ñ¡G2023 ¦~³Ç¥X¬ì¾Ç¦¨´N¼úÁ¿®y

diabetesjournals.org/diabetes/article/73/4/545/154111/The-Ailing-Cell-in-Diabetes-Insights-

From-a-Trip

²§±`ªº[£]²Ó­M] [¶t] °T¸¹¶Ç¾É¾É­P T1D µo¯f¾÷¨î.......

¥O¤HÅå³Yªº¬O¡A¶tªº´î¤Ö»PÅãµÛªº¤º½èºôÀ£¤Oªí«¬µLÃö¡A¦Ó¬O¾É­P[¤º½èºô¶t]ªºÅܤơA¾É­P[²É½uÅé¶t]¤ô¥­¤É°ª©M²É½uÅé¥\¯à»Ùê¡A³Ì²×¥[³t¿}§¿¯fªºµo¯f¡C

-------------------------------------------------------------------------------------------------

·|­û¡GROGER588910148151 µoªí®É¶¡:2024/6/12 ¤U¤È 05:09:10²Ä 3805 ½g¦^À³

2023.7.27-²Ó­M¤º[¶t]°T¸¹¶Ç¾É¡G±`¨£¶ûºÃ¤Hªº·N·Q¤£¨ìªº[·s¨¤¦â]!!!

www.ncbi.nlm.nih.gov/pmc/articles/PMC10413985/

...§ïÅܲӭM¾¹¶¡ Ca 2+³q¶qªº·L§®¥­¿Å¥i¯à¾É­P¦M¤Î¥Í©Rªº¯e¯f¡A¨Ò¦pAD¡BÀù¯g©M·»酶Åé¶J¿n¯g¡A¨Ã¥B¦b¥¼¨Ó¥i¯à·|µo²{§ó¦h¯e¯f...

-------------------------------------------------------------------------------------

·|­û¡GROGER588910148151 µoªí®É¶¡:2024/6/2 ¤W¤È 09:22:24²Ä 3751 ½g¦^À³

¥ÌÅS¾J(¶t/Áâ§l¦¬«O¯d)+¤T´â½©¿}(T1R3¿E°Ê¶tÁâ)¡u¤@¥[¤@¤j©ó¤G¡vªº®ÄÀ³!ªºÅܤơC

----------------------------------------------------------------------------------

Nature¥D¥Z(¿¯­¹²¢¨ý¾¯¤T´â½©¿}¬O T ²Ó­M¤¶¾É¤ÏÀ³ªº­t½Õ¸`¾¯--(¤T´â½©¿}´î¤Ö¤FT²Ó­M¤¤TCR¨Ì¿à©Ê¶t³q¶q¡A¦Ó¤£§ïÅܾãÅé²Ó­M¤º¶tÀx¦s)

·|­û:ROGER588910148151µoªí®É¶¡:2024/7/2 ¤W¤È 09:36:35²Ä3870½g¦^À³
2024.2.20-­P©Rªº¯×ªÕ¡G¯ØÅ¦¤º¯×½è¾É­P¯ØÅ¦Àù

www.cell.com/cell-reports-medicine/fulltext/S2666-3791(24)00051-X

¦b©s¼wº¸ÀH¾÷¤Æ©M«e¤©Ê¶¤¦C¬ã¨s¤¤¡A1¯ØÅ¦¤º¯×ªÕ·|¼W¥[¯ØÅ¦Àùªº­·ÀI¡C³o¬°¯×½è»P¯ØÅ¦Àù¯g¤§¶¡ªº¦]ªGÃö«Y´£¨Ñ¤F¦³»¡ªA¤Oªº¤HÃþÃÒ¾Ú¡A[ÃÒ¹ê¤F¼ï¦·©Ô°²»¡ªº¹w´ú]¡C

[ÃÒ¹ê¤F¼ï¦·©Ô°²»¡ªº¹w´ú]

·|­û:ROGER588910148151µoªí®É¶¡:2024/7/2 ¤W¤È 09:22:30²Ä3869½g¦^À³
www.sinewpharma.com/Upload/download/20240606-video.MP4

40¤À:¶}µoªvÀø¯×ªÕ[¯Ø]·s¥Î³~·sÃÄ

°ê»Ú3¤j³»¥ZCNS:Cell¡BNature¥H¤ÎScience¡C

¡u¥|¤jÂå¾Ç³»¥Z¡v¡G·s­^®æÄõÂå¾ÇÂø»x(NEJM)¡B¬h¸­¤M(Lancet)¡B¬ü°êÂå¾Ç·|Âø»x(JAMA)¥H¤Î­^°êÂå¾Ç´Á¥Z(BMJ)¡C

1.2023.4.21-¯ØÅ¦ªº¯×ªÕÅÜ¡G¯ØÅ¦¾Çªº¼ï¦·©ÔÅ]²°

www.thelancet.com/journals/langas/article/PIIS2468-1253(23)00064-X/abstract

2.2024.2.7-¤ñ¯×ªÕ¨x§óÄY­«ªº¯×ªÕ¯Ø¡Iwww.edh.tw/article/25090

¯×ªÕ¯Ø¬OÃöÁ䨤¦â

¯Ø®q¯À¬O¥Ñ¯Ø¸¢ªºBeta²Ó­M©Ò¤Àªc¡A¦Ó¯×ªÕ¹ï¯Ø¸¢¬O¦³¬r©Êªº¡C¬ã¨sµo²{¡A¦³¨Ç¤H¦b¯Ø¸¢¯×ªÕ§t¶q¶W¹L5¢Hªº®É­Ô¡A´N±w¦³

¤G«¬¿}§¿¯f¤F¡C [¯×ªÕ¨x] ¥[¤W[¯×ªÕ¯Ø]´N¬O³y¦¨¿}§¿¯fµLªk±±¨îªº¨â¤j­ì¦]¡A¤]ºÙ¬°[Âù´`Àô²z½×¡C]

---------------------------------------------------------------------------------

·|­û¡GROGER588910148151 µoªí®É¶¡:2023/8/30 ¤U¤È 05:53:57²Ä 3431 ½g¦^À³

1.¸É¤W¤T´â½©¿}Áý¾i¨S±w¤W1«¬¿}§¿¯f¡¨ªºP­È: 35%(P=0.021)¡A50%(P=0.012)¡C(°ª§C¿@«×ªºP<0.05¦³²Î­p¤WÅãµÛ®t²§)

2.§ïµ½¯×ªÕ¯Ø¤Þ°_ªº¯Ø¯fÅÜ¡B[¿}§¿¯f] ©Î¨ä¥L¬ÛÃö¯f¯g¤§²Õ¦Xª«¤Î¤èªk±M§Q (SNP-6ÃĪ«)

·|­û:ROGER588910148151µoªí®É¶¡:2024/6/30 ¤U¤È 07:18:40²Ä3868½g¦^À³
·sÃĶ}µoªº®Ú¥»:¨ä¥Hªk¥O¨î«×¬°¸g¡B¹êÃÒ¬ì¾Ç(Á{§É¸ÕÅç)¬°½n¡AÁa¾î¥æÂ´¦¨¬ì§Þ»Pªk«ß¥æ¬yªºÀ³¥Î¬ì¾Ç¡C

¦h°µÂI¥\½Ò¼W±j²´¥ú¡A³zµø©Ò§ë¸ê¤½¥qªº¸¬Äª¸Ì½æªº¬O¬Æ»òÃÄ?¿ï¾Ü¦³¼ç¤Oªº¤½¥q¡A´N¥i¥H´£°ª³Ó²v!

¤£­nªÈµ²©ó²{¦b¡A®æ§½©ñ¤j¤@ÂI¡A¦A©¹«e¬Ý·Q¹³¤@¦~«á¡B¤­¦~«á¡A¤@¤Á³£·|Åܱo¤£¤@¼Ë¡C

----------------------------------------------------------------------------------------------------

·|­û¡GROGER588910148151 µoªí®É¶¡:2022/9/11 ¤W¤È 08:01:05²Ä 2430 ½g¦^À³

¸¨¤«¤U¥Û??? §Ú¦b¹j¤é1/6°ê¹©ªÑ»ù¿ÄÂ_®É¦Ñ¦­Äµ¥Ü!!!(°ê¹©¤G´ÁP­ÈµS¥¼ª¾?)

¡u¤½µL´çªe¡A¤½³º´çªe¡C¼Zªe¦Ó¦º¡A·í©`¤½¦ó¡I¡v

----------------------------------------------------------------------------------------------------

·|­û¡GROGER588910148151 µoªí®É¶¡:2022/4/8 ¤U¤È 07:50:51²Ä 1878 ½g¦^À³

...¤µ¤Ñ±q¸Ñª¼¼Æ¾Ú¨Ó¬Ý [¥h¦~ªº¥[¦¬­«¯gªÌ] ´N¬O[»´¤¤¯g¦³®Ä©Ê«Ü¤£©úÅã¡A©Ò¥H¥[¤J­«¯g±wªÌÁ{§É]

---------------------------------------------------------------------------------------------------

·|­û¡GROGER588910148151 µoªí®É¶¡:2021/12/29 ¤U¤È 01:47:04²Ä 1534 ½g¦^À³

...°ê¹©:DMC«ØÄ³¼W¥[¦¬ªv»Ý­n®ñ®ð¤ä«ù¤§­«¯g¦í°|¯f±w¡C

³o®É¦³2ºØ¥i¯à©Ê:¤@¬O¦³®Ä©Ò¥H¥[¤J­«¯g±wªÌ¡A¤G¬O¥i¯à»´¤¤¯g¦³®Ä©Ê¤£©úÅã¡A©Ò¥H¥[¤J­«¯g±wªÌÁ{§É¬Ý¬Ý¡C

·|­û:ROGER588910148151µoªí®É¶¡:2024/6/30 ¤U¤È 06:58:03²Ä3867½g¦^À³
·|­û¡GROGER588910148151 µoªí®É¶¡:2021/2/3 ¤W¤È 10:56:59²Ä 662 ½g¦^À³

J&J»PGSKªº°ª¼h¬OÄø³J?¥H«e¹C»¡°ê·|ij­ûªý¼¸FDA¡A²{¦b¤£ª¾¹D¤Ï¹L¨Ó§Q¥Î³o±ø¡m«D³B¤èÃĦw¥þ¡A³Ð·s©M§ï­²ªk®×¡n???¬°½T«OOTCÃÄ«~ªº[¦w¥þ©Ê]¡A FDA¥u»Ý¤@¯È¦æ¬F©R¥O...

-------------------------------------------------------------------------------------------------

2023.7.28www.gao.gov/assets/gao-23-106570.pdf

¬ü°êFDA[«D³B¤èÃÄ]¤¤±Æ¥L©Ê±ø´Ú(¥«³õ¿W¦ûÅv)

...2018 ¦~1 ¤ë¼gµ¹°ê·|»â¾É¤Hªº¤@«Ê«H¤¤¡A¤@­Ó¥Nªí®ø¶OªÌ§Q¯qªº²Õ´¤½¶}´£¥X¤F³o¼Ëªº¾á¼~¡G«D³B¤èÃĤ½¥q¥i¯à·|­­¨î¸û¦Ñ¦ý¦P¼Ë¦³®Äªº«D³B¤èÃĪº¨ÑÀ³¡A±q¦Ó­¢¨Ï®ø¶OªÌÁʶR¸û·s¡B¸û¶Q¥BÀò±o[¿W®a¸gÀçÅv]ªºÃĪ«

­Ó¤Hµ²½×:¤jÃļt©ñ±ó[¿W®a¸gÀçÅv]? ©ñ±ó±q®ø¶OªÌ¤f³U±Ç§ó¦h¿ú?

·|­û:ROGER588910148151µoªí®É¶¡:2024/6/30 ¤W¤È 09:21:00²Ä3866½g¦^À³
ªYÄ£ªº¥Ø¼Ð¬O´Â¦V¥H°ª¨x¦w¥þ©Êªº¤AñQÓi×ô¡u¨ú¥N¡v²{¦³¤AñQÓi×ôªº¥«³õ¡C

¤jÃļt·|«ç¼Ëª¾ªkª±ªk¡A¥HOTC±M½×­q³æ½Ð¨D¦J÷ÅýFDAµo¥¬¦æ¬F©R¥O.....???? ³o¬OµL¨x¬rSNP-810ªºOTC«D³B¤èÃÄ»ù­È¡I

·|­û:ROGER588910148151µoªí®É¶¡:2024/6/30 ¤W¤È 08:53:22²Ä3865½g¦^À³
·|­û¡GROGER588910148151 µoªí®É¶¡:2024/6/7 ¤U¤È 07:05:38²Ä 3781 ½g¦^À³

...§ï­²ªk®×¤º¤å¦³¹ªÀy«D³B¤èÃÄ[¦w¥þ³Ð·s]!

--------------------------------------------------------------------------------------------------

ªYÄ£ªº¥Ø¼Ð¬O´Â¦V¥H°ª¨x¦w¥þ©Êªº¤AñQÓi×ô¡u¨ú¥N¡v²{¦³¤AñQÓi×ôªº¥«³õ¡C

Ãļt¥i¥H­n¨DFDA§ó§ï¨Ï¥Î±ø¥ó©Î¦¨¤À.....µ¥--->´£¥æ(OTC±M½×­q³æ½Ð¨DOMOR¡^

sbiaevents.com/files2024/OMUFA-Webinar-June-2024-Slides.pdf

¹ï©ó·s¼W©Î¥[±j¥H¤U [¦w¥þ¬ÛÃö] «D³B¤èÃıMµÛÅܧó¡AµL½×µ¥¯Å¬°¦ó¡AOMOR §¡¤£¦¬¨ú¥ô¦ó¶O¥Î(¨ä¾lÅܧó­n¦¬¿ú)¡G

¸T§Ò¯g¡Bĵ§i©Î¹w¨¾±¹¬I

Ãö©ó¨Ï¥Î©ÎÀݥάÛÃöªº­·ÀIªºÁn©ú

¦³Ãö¾¯¶q©Mµ¹ÃĪº»¡©ú¡A¦®¦b´£°ª«D³B¤èÃıMµÛÃĪ«ªº¦w¥þ¨Ï¥Î

­Ó¤Hµ²½×:´Á«Ý¹Ú¹Ò¦¨¯u¡A¥@¬É¦]¹Ú¦Ó§ïÅÜ!

·|­û:ROGER588910148151µoªí®É¶¡:2024/6/30 ¤W¤È 08:35:24²Ä3864½g¦^À³
·|­û¡GROGER588910148151 µoªí®É¶¡:2024/6/25 ¤U¤È 10:58:33²Ä 3854 ½g¦^À³

...Ãļt§ä¥Á¥N¬IÀ£FDA-[¥P©é¥P]À¸½Xµ²§ô!

2024.6.14-¬ü°ê­×§ï«áªº«D³B¤èÃıMµÛ­p¹ºÅܧó±q¹ï¤AñQ®ò°ò×ô¥Ö½§¤ÏÀ³Äµ§i¶}©l

¤µ¤Ñ¡AFDA µo¥¬¤F¤@¶µÀÀijªº[¦æ¬F©R¥O]....

--------------------------------------------------------------------------------------------------

Ãļt¥i¥H­n¨DFDA§ó§ï¨Ï¥Î±ø¥ó©Î¦¨¤À.....µ¥--->´£¥æ(OTC±M½×­q³æ½Ð¨DOMOR¡^

FDA­n¨DÃļt¥[µùĵ§i»y.....µ¥--->¥Îªº¬O(¦æ¬F©R¥O)

·|­û:ROGER588910148151µoªí®É¶¡:2024/6/30 ¤W¤È 08:21:31²Ä3863½g¦^À³
www.sinewpharma.com/Upload/download/20240606-video.MP4

39¤À30¬í:¤À§O¦V¨äFDA»PEMA±N¨ä¾Ö¦³¨x¬r©Ê......²¾¥X¥«³õ....

­Ó¤Hµ²½×:¤jÃļtªºª¾ªkª±ªk¡A§ó¥i©È!!!

----------------------------------------------------------------------------------------------

·|­û¡GROGER588910148151 µoªí®É¶¡:2024/6/7 ¤U¤È 08:31:15²Ä 3782 ½g¦^À³

ªYÄ£±N¥Ó½Ð¦w¥þ·sÃij\¥iÃÒ(¥«³õ±MÀçÅv?)¨Ã´£¨Ñµ¹°ê»Ú¤jÃļt(°ê»Ú¤jÃļt¤£¥Î­«·s°µÁ{§É¥Ó½ÐÃÄÃÒ)

3.[FDA...¦æ¬F©R¥O±Â¤©[¥«³õ±MÀçÅv][¥«³õ±MÀçÅv][¥«³õ±MÀçÅv]

...OTCÃÄ«~§ï­² (SNP-810¦³¾¯«¬±M§Q¡A¦w¥þ½d³ò¤j¡A¥i­×§ï©Î§R°£FDA¨x¬rĵ»y¡C¥i­×§ï©Î§R°£FDA¨x¬rĵ»y)

1.³Ì²×¦æ¬F©R¥Oµo¥¬«á¡AFDA ¥i¥H§ó§ï¶Ü¡H

¦³¤@¶µ±ø´Ú¤¹³\ FDA ¦b¦³·sÃÒ¾Úªí©ú¯S©wÃĪ«©Î¬YÃþÃĪ«ºc¦¨[¤£¨}¨Æ¥ó]ªº[¤£¦X²z­·]ÀI¨Ã»Ý­n¼ÐÅҩΨä¥LÃþ«¬ªº§ó§ï

®É¡A¤¹³\FDA ¹ï¥ô¦ó³Ì²×¦æ¬F©R¥O¶i¦æ§ó§ï¡C

2.»s³y°Ó¦p¦ó½Ð¨D§ó§ï±M½×¡H

»s³y°Ó¥i¥H­n¨D§ó§ï¨Ï¥Î±ø¥ó©Î¦¨¤À¡A¨Ò¦p³z¹L´£¥æ OTC ±M½×­q³æ½Ð¨D¡]¡uOMOR¡v¡^¡C

3.¦b·sªº«D³B​​¤èÃĺʺޮج[¤U¡A§Úªº«D³B¤èÃĦ³¸ê®æÀò±o¯S³\¸gÀçÅv¶Ü¡H

¦pªG·sªº¤HÅé¬ã¨s¹ïµo¥¬³Ì²×¦æ¬F©R¥O¦ÜÃö­«­n¡A¨º»òFDA ¥i¥H¦bµo¥¬¥Ñ¥Ó¿ìªÌµo°_ªº°w¹ï·s«D³B¤èÃĬ¡©Ê¦¨¤À¡]¤§«e¥¼

¦C¤J¦U½×©Î©R¥O¡^ªº³Ì²×¦æ¬F©R¥O©Î°w¹ï¤£¦P¨Ï¥Î±ø¥óªº¦æ¬F©R¥O«á±Â¤©¥«³õ±MÀçÅv¡C

·|­û:ROGER588910148151µoªí®É¶¡:2024/6/29 ¤U¤È 03:27:16²Ä3862½g¦^À³
2024.6.6-ªk»¡·|¼v­µÀÉ httpd://www.sinewpharma.com/Upload/download/20240606-video.MP4

¯u¹ê.°È¹ê.¥­¹ê

·|­û:ROGER588910148151µoªí®É¶¡:2024/6/27 ¤U¤È 01:25:35²Ä3861½g¦^À³
¥ÌÅS¾J¥i¯à«ì´_¨ã¦³¦h¥\¯à©Ê©M¸~½F²M°£¯à¤OªºCD8 + T ²Ó­M¾÷¨î???

°ªº¯³zÀ£[¥ÌÅS¾J]«á¦å¼ß[¹[¿@«×]¤É°ª¬O¥Ñ©ó[K+¹[]±q²Ó­M [²¾¥X] ¶i¤J²Ó­M¥~²G...

--------------------------------------------------------------------------------------

1.2016.9.14(Nature¥D¥Z)¸~½F·LÀô¹Ò¤¤ªºÂ÷¤l§K¬Ì§í¨î­­¨î¤F T ²Ó­M®ÄÀ³¥\¯à

www.nature.com/articles/nature19364

¸~½F¤ºT²Ó­Mªº±þÀù¬¡©Ê©¹©¹·|¨ü¨ì¼vÅT¡A¾É­P¯e¯f¶i®i¡C§Ú­Ì¥ý«eµo²{¡A¸~½F¤º²Ó­M [¥~] K+ ªº¤É°ª»P¥¿¦b¶i¦æªº²Ó­M¦º¤`¦³Ãö¡A³o­­¨î¤F CD8+ T ²Ó­Mªº Akt-mTOR °T¸¹¶Ç¾É©M®ÄÀ³¥\¯à¡C¬°¤F½w¸Ñ K+ ¤¶¾Éªº T ²Ó­M§í¨î¡A§Ú­Ì³z¹L°ò¦]¤â¬q¨Ó­°§C²Ó­M[¤º]K+¡C

2.2019.3.29-¸~½F¤¤ªºT²Ó­M·F©Ê©M¥\¯à»Ùê¬O¥Ñ¦@¦P¾÷¨îIJµoªº

www.science.org/doi/full/10.1126/science.aau0135

§Ú­Ìµo²{¸~½F·LÀô¹Ò¤¤¹L¶qªº [¹[]¬O³oºØ [¤G¤Àªk] ªº°ò¦¡A¦b«O«ù·F©Êªº¦P®ÉIJµo T ²Ó­M®ÄÀ³¥\¯àªº§í¨î¡C°ª¤ô¥­ªº²Ó­M [¥~] ¹[³z¹L­­¨îÀç¾i§l¦¬¨Ó­­¨îT ²Ó­M®ÄÀ³µ{§Ç¡A±q¦Ó»¤¾É¦Û¾½§@¥Î¨Ã´î¤Ö®ÄÀ³¾¹©M¯ÓºÜ¦ìÂIªº²Õ³J¥Õ¤AñQ¤Æ¡A

¶i¦Ó²£¥Í¨ã¦³§ïµ½ªºÅ餺«ù¤[©Ê¡B¦h¯à©Ê©M¸~½F²M°£¯à¤OªºCD8 + T ²Ó­M¡C

¶i¦Ó²£¥Í¨ã¦³§ïµ½ªºÅ餺«ù¤[©Ê¡B¦h¯à©Ê©M¸~½F²M°£¯à¤OªºCD8 + T ²Ó­M¡C

³oºØ¾÷¨îª¾ÃѼW¶i¤F§Ú­Ì¹ï T ²Ó­M¥\¯à»Ùꪺ²z¸Ñ¡A¨Ã¥i¯à±a¨Ó·sªº¤èªk¡A±q¦Ó¯à°÷¶}¾v¥Î©óÀù¯g§K¬ÌªvÀøªº¼W±j T ²Ó­Mµ¦²¤¡C

·|­û:ROGER588910148151µoªí®É¶¡:2024/6/27 ¤W¤È 11:52:21²Ä3860½g¦^À³
¥ÌÅS¾J(º¯³zÀ£½Õ±±NFAT5ªº¬¡¤Æ¥[¼@¸~½F®û¼íCD8+T²Ó­Mªº¯ÓºÜ?)+¤T´â½©¿}(§í¨îCD4+ CD8+ T ²Ó­M¼W´Þ)ªº¨ó¦P®ÄÀ³!!!

1.2023.10.9-¡m¦ÛµM§K¬Ì¾Ç¡n¡G¬¥®á¤j¾Ç¹Î¶¤µo²{±Mªù½Õ¸`¸~½F¤¤T²Ó­M¯ÓºÜªº¯S®í³J¥Õ¡I

www.nature.com/articles/s41590-023-01614-x

¬ã¨s´¦¥Ü¡ANFAT5ªº°ªªí²{¯à°÷¥[¼@¸~½F®û¼íCD8+T²Ó­Mªº¯ÓºÜ¡A©Î¥i§@¬°¼ç¦bªº§K¬ÌªvÀø¹vÂI¡A³z¹L¤¶¤JNFAT5ªº[ªí¹F©Î

¬¡©Ê]¨Ó´£°ªCD8+T²Ó­M¹ï¸~½Fªº¤ÏÀ³¡A±q¦Ó§ïµ½Àù¯gªvÀøªº®ÄªG¡C

NFAT5ªº¬¡¤Æ¨ü²Ó­M¥~ [º¯³zÀ£½Õ±±]

NFAT5ªº¬¡¤Æ¨ü²Ó­M¥~ [º¯³zÀ£½Õ±±]

NFAT5ªº¬¡¤Æ¨ü²Ó­M¥~ [º¯³zÀ£½Õ±±]

......NFAT5¹ï©ó¨ä¥¦¨ë¿E±ø¥ó¡A¦p®ñ¤ÆÀ£¤O¡B¯Ê®ñ¡B²Ó­M¿E¯À¡B¨ë¿E¤£±Ó·P¡C

2.2013.7.19-¬¡©Ê®ñ½Õ¸` NFAT5 ¼Ð¹v°ò¦]ªºÀô¹Ò¨Ì¿à©Ê§í¨î www.nature.com/articles/emm201361

[°ªº¯³zÀ£] ¥ÌÅS¾J]¾¯¶q¨Ì¿à©Ê»¤¾É NFAT5 ¬¡©Ê¡A¦ý´î¤Ö LPS »¤¾Éªº IL-6 ²£¥Í¡C

3.2016.7.28-¾AÀ³©Ê§K¬Ì¨t²Î¦b¨x·l¶Ë©M¨x²Ó­MÀùµo®i¤¤ªºÂù­«§@¥Î

www.cell.com/cancer-cell/fulltext/S1535-6108(16)30269-0?_returnURL=https%3A%2F%2Flinkinghub.elsevier.com%2Fretrieve%2Fpii%2FS1535610816302690%3Fshowall%3Dtrue

CD8 +²Ó­Mªº¬¡¤ÆÅãµÛ«P¶i¨xÀùªºµo¥Í¡C CD8 +²Ó­M¯ÓºÜªº¤p¹«ÀH«á§¡¥¼¥X²{¨x¸~½F

§Ú­Ìªº¼Æ¾Ú½T©w CD8 + T ²Ó­M¬Oµoª¢¬ÛÃö¨xÀùµo¥ÍªºÃöÁä²Ó­M¦¨¤À¡C

------------------------------------------------------------------------------------------------

·|­û¡GROGER588910148151 µoªí®É¶¡:2024/6/24 ¤U¤È 05:31:04²Ä 3847 ½g¦^À³

1. 2023.3.15-Nature¥D¥Z-¿¯­¹²¢¨ý¾¯[¤T´â½©¿}]¬O[T²Ó­M]¤¶¾É¤ÏÀ³ªº­t½Õ¸`¾¯

¤T´â½©¿}Åã²{§í¨îCD4+ CD8+ T ²Ó­M¼W´Þªº¾¯¶q¨Ì¿à©Ê¯à¤O

·|­û:ROGER588910148151µoªí®É¶¡:2024/6/27 ¤W¤È 09:40:22²Ä3859½g¦^À³
2023/08/17 10:24

¡e°OªÌ·¨°ê¤å¡þ¥x¥_³ø¾É¡f³Ò°Ê³¡³Ò°Ê°òª÷¹B¥Î§½°ê¤º§ë¸ê²Õ«e²Õªø´å°i¤å¡A³Q±±©ó¥ô¤º»P®É¥ôÄ_¨Î¶°¹Î°õ¦æªø­ð·¡¯Pµ¥¤H¦X§@¡A¾Þ±±³Ò°Ê°òª÷¡A°ª»ù©Ó±µÄ_¨Î¶°¹Î¡u­Ë³f¡v¥X²æªº18¸U±i»·ªF¦Ê³fªÑ²¼¡A¨ÏÄ_¨ÎÀò§Q¬ù4.5»õ¤¸¡A¤@¼f¨Ì¶¡±µ¾ÞÁaªÑ»ù¸o­«§P´å°i¤å9¦~¡B­ð·¡¯P8¦~....

-------------------------------------------------------------------------------------------------

¬ÝµÛ­·ÀY»¡¸Ü¡A¤jªÑªF¤£§C½Õ? ¨S±ÂÅv«e·Q¦³¬ßÀY¡A¬Ýú³°Ó·Q³y¶Õ§_?

·|­û:ROGER588910148151µoªí®É¶¡:2024/6/27 ¤W¤È 09:30:17²Ä3858½g¦^À³
¥xÆW°·«O¸p¤½§G ¥h¦~2023¥xÆW¤Hªº°·«O¥ÎÃıƦæ:

[¨Ï¥Î¤H¼Æ³Ì¦h]ªºÃĪ«¬O¦¨¤À¬°¤AñQ®ò×ôªº¤îµhÃÄ¡A¨Ï¥Î¤H¼Æ¹F898¸U¤H¡A±Æ¦W²Ä¤@

·|­û:dk10140377µoªí®É¶¡:2024/6/27 ¤W¤È 09:12:14²Ä3857½g¦^À³
¦Aµ¹¥D¤O¤@¦¸¥X³fªº¾÷·|¡A¥þ¥x¬y·P¡B¤­º~ªÍª¢¤S¨Ó¤F¡C¤îµhÃħ½¨Ó¬Ý¬Ý
·|­û:ROGER588910148151µoªí®É¶¡:2024/6/26 ¤W¤È 07:48:54²Ä3856½g¦^À³
·|­û¡GROGER588910148151 µoªí®É¶¡:2024/4/19 ¤W¤È 08:18:34²Ä 3698 ½g¦^À³

2017.9.14-¬ü°ê°ê·|¼f¬d«D³B¤èÃÄ ¨âÄҥߪk¯ó®×±N¹ý©³§ï­² FDA ¹ï«D³B¤è²£«~ªººÊºÞ¤è¦¡(¦]¬°¤¾ªøªk³Wµ{§Ç¡AFDA ªá¤F¤C¦~®É¶¡¤~­n¨D¹ï¤AñQÓi×ôµo¥X¨xŦ¬r©Êĵ§i)

----------------------------------------------------------------------------------------------

¤T¶¥¬q³W«h¨î©w¬yµ{¡]ANPR¡BTFM ©M FM¡^¤¾ªøªk³Wµ{§Ç-->FDA ªá¤F¤C¦~®É¶¡¤~­n¨D¹ï¤AñQÓi×ôµo¥X¨xŦ¬r©Êĵ§i)

2024¦~6¤ë14¤é¤@¯È[¦æ¬F©R¥O]--->[«D³B¤èÃÄ]±MµÛ­p¹ºÅܧó±q¹ï¤AñQ®ò°ò×ô [¥Ö½§¤ÏÀ³]ĵ§i¶}©l¡C

§ñÃö¦w¥þ©Êªº¨x¬r¦p¦ó¸Ñ??????

·|­û:ROGER588910148151µoªí®É¶¡:2024/6/26 ¤W¤È 07:36:27²Ä3855½g¦^À³
1.2017.09.13-«eFDA¥N²z§½ªøJanet Woodcock¦b²³Ä³°|³Æ¸ß¸ê®Æ:

We could start with the skin reactions to acetaminophen.

(§Ú­Ì¥i¥H±q¹ï¤AñQ®ò°ò×ôªº¥Ö½§¤ÏÀ³¶}©l)

2.2020.3.27-¤t´¶Ã±¸p¡m«D³B¤èÃĦw¥þ¡A³Ð·s©M§ï­²ªk®×¡n¥´³qFDA¥ô·þ¤G¯ß!!!

¤T¶¥¬q³W«h¨î©w¬yµ{¡]ANPR¡BTFM ©M FM¡^±N³Q¦æ¬F©R¥O¬yµ{¨ú¥N¡C

3.2024.6.14-¬ü°ê­×§ï«áªº[«D³B¤èÃÄ]±MµÛ­p¹ºÅܧó±q¹ï¤AñQ®ò°ò×ô [¥Ö½§¤ÏÀ³]ĵ§i¶}©l

-------------------------------------------------------------------------------------------------

µL¨x¬r¹ï¤AñQ®ò°ò×ô²Å¦X¤Þ¥Î3.³o±øªk³W???

3.¦b [·sªº«D³B​​¤èÃÄ] ºÊºÞ®Ø¬[¤U¡A§Úªº«D³B¤èÃĦ³¸ê®æÀò±o¯S³\¸gÀçÅv¶Ü¡H

¦pªG [·sªº¤HÅé¬ã¨s] ¹ïµo¥¬ [³Ì²×¦æ¬F©R¥O] ¦ÜÃö­«­n¡A¨º»òFDA ¥i¥H¦bµo¥¬¥Ñ¥Ó¿ìªÌµo°_ªº°w¹ï·s«D³B¤èÃĬ¡©Ê¦¨¤À¡]¤§«e¥¼¦C¤J¦U½×©Î©R¥O¡^ªº³Ì²×¦æ¬F©R¥O©Î°w¹ï¤£¦P¨Ï¥Î±ø¥óªº¦æ¬F©R¥O«á±Â¤© [¥«³õ±MÀçÅv]¡C

·|­û:ROGER588910148151µoªí®É¶¡:2024/6/25 ¤U¤È 10:58:33²Ä3854½g¦^À³
·|­û¡GROGER588910148151 µoªí®É¶¡:2021/1/31 ¤W¤È 09:39:52²Ä 646 ½g¦^À³

Ãļt¸òFDA [¥P©é¥P]À¸½Xµ²§ô!

2017.09.13 ²{¥N¤ÆFDAªk³W«D³B¤èÃĪ« FDAÃĪ«µû¦ô»P¬ã¨s¤¤¤ß¡]CDER ¡^¥D¥ôJanet Woodcock¦b²³Ä³°|³Æ¸ß¸ê®Æ

www.govinfo.gov/content/pkg/CHRG-115hhrg27228/html/CHRG-115hhrg27228.htm

...Dr. Woodcock. OK. Well, we could start with the skin reactions to acetaminophen.

-------------------------------------------------------------------------------------------------

Ãļt§ä¥Á¥N¬IÀ£FDA-[¥P©é¥P]À¸½Xµ²§ô!

2024.6.14-¬ü°ê­×§ï«áªº«D³B¤èÃıMµÛ­p¹ºÅܧó±q¹ï¤AñQ®ò°ò×ô¥Ö½§¤ÏÀ³Äµ§i¶}©l

www.fda.gov/drugs/drug-safety-and-availability/fda-issues-agency-initiated-proposed-order-regarding-otc-monograph-drugs-containing-acetaminophen

¤µ¤Ñ¡AFDA µo¥¬¤F¤@¶µÀÀijªº[¦æ¬F©R¥O]¡A¥H¸Ñ¨M»P§t¦³¹ï¤AñQ®ò°ò×ôªº«D³B¤è (OTC) ±MµÛÃÄ«~¬ÛÃöªº¦w¥þ°ÝÃD¡C

...FDA ÃĪ«µû¦ô»P¬ã¨s¤¤¤ß«D³B¤èÃĿ줽«Ç¥D¥ô Theresa Michele Âå¾Ç³Õ¤hªí¥Ü¡G¡§¤µ¤Ñªº¦æ°Ê¥Nªí¤F FDA ¹ê¬I°ê·|·s±ÂÅv¡]§@¬° OTC ±M½×§ï­²ªº¤@³¡¤À¡^ªº­«­n¨½µ{¸O¡C¡¨ ¡§¤µ¤Ñ´£¥Xªº©R¥O¦³§U©ó½T«O§Ú­Ì¥«³õ¤W«D³B¤èÃĪº¦w¥þ©Ê©M¦³®Ä©Ê¡C¡¨

·|­û:ROGER588910148151µoªí®É¶¡:2024/6/25 ¤W¤È 07:25:44²Ä3853½g¦^À³
2024.4.2--³o³U²Ó­M¥i¥H¦b¤HÅ餺ªø¥X·sªº¨xŦ(IIa´Á¸ÕÅç²×¥½´Á¨x¯f(ESLD)

---------------------------------------------------------------------------------------------

¹L¥hªº¤Q¦~......¥L­Ìªº¤èªk¦b¦Ñ¹«¡B½Þ©Mª¯¨­¤W°ö¨|·sªº°g§A¨xŦ-->8¦¨¾÷²v¦b¤HÅ餺ªø¥X·sªº°g§A¨xŦ!

±µ¨ü¨x²Ó­M²¾´ÓªÌ²×¥Í»Ý­nªA¥Î§K¬Ì§í¨î¾¯(´N¹³±µ¨ü²¾´Ó¾¹©xªÌªA¥Î§Ü±Æ¥¸ÃĪ«¤@¼Ë)-->³oÂI·¥¤j­­¨î¤F¾A¥Î±wªÌ!

§Ú­n¦^À³¥»¸ÜÃD
·|­û:
§@ªÌ:
¬ÛÃöªÑ²¼¤½¥q¦WºÙ:ªYÄ£¥ÍÂå
¤º®e:
½Ð¥ýµn¤J­Y±z©|µL·|­û¨­¤À¡A½Ð¥ý¥Ó½Ð±b¸¹
°Q½×°Ï¬ÛÃö³W©w¡G
1.­Y±b¸¹¶¢¸m¹L¤[¨t²Î·|¦Û°Êµn¥X¡A«ØÄ³¦b¼g¦n¤å³¹¨Ã¥B©|¥¼µo°e¤§«e¥ý¦æ½Æ»s¡A¥H§Kµo°e¥¢±Ñ«á¾É­P¤º¤å®ø¥¢¡I
2.½Ð¤Å°Q½×ªÑ²¼¶R½æ©Î´£¤Î¦¨¥æ»ù¦ìµ¥¨Æ©y¡A¤Z¬O¯d¤U¬ÛÃö¥æ©ö°T®§¡A¥»ºô±N¦Û°Ê§R°£¡A¹HªÌ±NµLªkÄ~Äò°Ñ»P°Q½×¡I
3.ÄY¸T¯d¤UÁpµ¸¤è¦¡¡A½Ñ¦pLINE¡BFB¡BE-mail¡B¹q¸Ü..µ¥¡A©Î¥H¥ô¦ó©ú¥Ü¡B·t¥Üµ¥¤âªk¶i¦æÁpµ¸¡A¹HªÌ±NµLªkÄ~Äò°Ñ»P°Q½×¡I
4.¬°Á×§K®ö¶Oºô¸ô¸ê·½¡A½Ð¤Å±N¬Û¦P¤º®e³sÄòµo¦b¦h­Ó¤£¦P¥DÃD¤º¡A©ÎªÌ³sÄòµo°e¦h­Ó·s¥DÃD¡A­Y¦³¦¹Ãþ¬~ª©¤§¦æ¬°±NµLªkÄ~Äò°Ñ»P°Q½×¡I
5.ÄY¸T·N¹ÏÂǥΥ»ºô¥­¥x¤½µM´²¥¬¤å¦r©ó²³¡A¦Ó«üÂÖ¡B«V°d©Î¶Ç­z¨¬¥H·´·l¥L¤H¦WÅA¤§¨ÆªÌ¡A­Y¦]¦Ó¯A¤Îªk«ß°ÝÃD¡A·§»P¥»¤½¥qµLÃö¡A·q½Ð¿í¦u¡C

·q½Ð´L­«¥»ºô¤§¸gÀç²z©À¨Ã¿í¦uª©³W¡AÁÂÁ¡C

¼s§i¦X§@ ¥¼¤W¥«ÂdªÑ²¼¬d¸ß ¥¼¤W¥«ºô¯¸¾ÉÄý ¥¼¤W¥«ÂdªÑ²¼±MÃD ¿³ÂdªÑ²¼±MÃD ¥¼¤W¥«ªÑ²¼-¶°¹Î¤ÀÃþ ²§·~Âà§ë¸ê¥Í§Þ·~ ¤U³æ±Ð¾Ç
¥¼¤W¥«|¥¼¤W¥«ªÑ²¼|³Ì±M·~ªº  ¥xÆW¥¼¤W¥«ªÑ²¼  °]¸gºô¯¸-Copyright©2022¡£¥²´Iºô¡¤ §K¥I¶OªA°È±M½u:0800-035-178 ªA°È«H½c:postmaster@berich.com.tw
¥»ºô¯¸¬° ¥¼¤W¥«ÂdªÑ²¼¬d¸ß,¥¼¤W¥«ªÑ²¼§Y®É·s»D,¥¼¤W¥«¤½¥q¤½§i,¿³ÂdªÑ²¼¶R½æ,·Ç¤W¥«ªÑ²¼,¤¤ÅҪѬÛÃö¸ê°T¤À¨É¥æ¬yªÀ¸sºô¯¸,¸ê®Æ¶È¨Ñ°Ñ¦Ò,¨Ï¥ÎªÌ½Ð¦Û¦æ·r°u!
¥»ºô¯¸¤£¤¶¤J·|­û¶¡¤§¥¼¤W¥«ªÑ²¼¶R½æ,³æ¯Â´£¨Ñ¥¼¤W¥«ªÑ²¼¦æ±¡,«ùªÑÂàÅý,¥¼¤W¥«ªÑ²¼¹L¤á¿Ô¸ß¶È´£¨Ñ¥¼¤W¥«ªÑ²¼¥æ©ö¥­¥xµ¹·|­û¨Ï¥Î,¨Ì¥»¸ê®Æ¥æ©ö«á¬ÕÁ«¦Û­t!